{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                "http://www.ncbi.nlm.nih.gov/pubmed/20403221",
                "http://www.ncbi.nlm.nih.gov/pubmed/18215414",
                "http://www.ncbi.nlm.nih.gov/pubmed/19095716",
                "http://www.ncbi.nlm.nih.gov/pubmed/19154407",
                "http://www.ncbi.nlm.nih.gov/pubmed/27726944",
                "http://www.ncbi.nlm.nih.gov/pubmed/20042385",
                "http://www.ncbi.nlm.nih.gov/pubmed/22575867",
                "http://www.ncbi.nlm.nih.gov/pubmed/21574432"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Telomerase activation and alternative lengthening of telomeres are two major mechanisms of telomere length maintenance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 120,
                    "offsetInEndSection": 212,
                    "text": "Soft tissue sarcomas appear to use the alternative lengthening of telomeres more frequently."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 213,
                    "offsetInEndSection": 454,
                    "text": "Loss of \u03b1-thalassemia/mental retardation syndrome X-linked (ATRX) or death domain-associated protein 6 (DAXX) expression has been implicated in the pathogenesis of alternative telomere lengthening in pancreatic endocrine neoplasm and glioma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 455,
                    "offsetInEndSection": 552,
                    "text": "The mechanism leading to the alternative lengthening of telomeres in liposarcoma remains unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 553,
                    "offsetInEndSection": 747,
                    "text": "Whereas alternative telomere lengthening was determined to be an indicator of poor prognosis in liposarcomas as a whole, its prognostic power has not been verified in any subtype of liposarcoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 1069,
                    "text": "In this study, we characterized the status of alternative telomere lengthening and expression of ATRX and DAXX in 111 liposarcomas (28 well-differentiated, 52 dedifferentiated, 20 myxoid or round cell, and 11 pleomorphic liposarcomas) by telomere fluorescence in situ hybridization and immunohistochemistry, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1070,
                    "offsetInEndSection": 1267,
                    "text": "Alternative lengthening of telomere was observed in 0% (0/16) of well-differentiated, 30% (14/46) of dedifferentiated, 5% (1/19) of myxoid or round cell, and 80% (8/10) of pleomorphic liposarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1268,
                    "offsetInEndSection": 1364,
                    "text": "Eighteen (16%) and one (1%) tumors were negative for ATRX and DAXX immunostaining, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1365,
                    "offsetInEndSection": 1575,
                    "text": "Remarkably, all cases with loss of either ATRX or DAXX expression had alternative lengthening of telomeres, and 83% (19/23) of tumors that had alternative lengthening of telomeres showed loss of either protein."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                "http://www.ncbi.nlm.nih.gov/pubmed/22917661",
                "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                "http://www.ncbi.nlm.nih.gov/pubmed/26116622",
                "http://www.ncbi.nlm.nih.gov/pubmed/25811804",
                "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                "http://www.ncbi.nlm.nih.gov/pubmed/27911795",
                "http://www.ncbi.nlm.nih.gov/pubmed/23963681",
                "http://www.ncbi.nlm.nih.gov/pubmed/26993043"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 38,
                    "text": "Understanding the Physiology of FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Fibroblast growth factor 21 (FGF21) is a peptide hormone that is synthesized by several organs and regulates energy homeostasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 310,
                    "text": "Excitement surrounding this relatively recently identified hormone is based on the documented metabolic beneficial effects of FGF21, which include weight loss and improved glycemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 311,
                    "offsetInEndSection": 500,
                    "text": "The biology of FGF21 is intrinsically complicated owing to its diverse metabolic functions in multiple target organs and its ability to act as an autocrine, paracrine, and endocrine factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 501,
                    "offsetInEndSection": 678,
                    "text": "In the liver, FGF21 plays an important role in the regulation of fatty acid oxidation both in the fasted state and in mice consuming a high-fat, low-carbohydrate ketogenic diet."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 679,
                    "offsetInEndSection": 782,
                    "text": "FGF21 also regulates fatty acid metabolism in mice consuming a diet that promotes hepatic lipotoxicity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 783,
                    "offsetInEndSection": 914,
                    "text": "In white adipose tissue (WAT), FGF21 regulates aspects of glucose metabolism, and in susceptible WAT depots, it can cause browning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 915,
                    "offsetInEndSection": 1045,
                    "text": "This peptide is highly expressed in the pancreas, where it appears to play an anti-inflammatory role in experimental pancreatitis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1046,
                    "offsetInEndSection": 1102,
                    "text": "It also has an anti-inflammatory role in cardiac muscle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1103,
                    "offsetInEndSection": 1243,
                    "text": "Although typically not expressed in skeletal muscle, FGF21 is induced in situations of muscle stress, particularly mitochondrial myopathies."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                "http://www.ncbi.nlm.nih.gov/pubmed/18247557",
                "http://www.ncbi.nlm.nih.gov/pubmed/27956554",
                "http://www.ncbi.nlm.nih.gov/pubmed/25742093",
                "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                "http://www.ncbi.nlm.nih.gov/pubmed/29074978",
                "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                "http://www.ncbi.nlm.nih.gov/pubmed/18793140",
                "http://www.ncbi.nlm.nih.gov/pubmed/26003431"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Neural-precursor-cell-expressed developmentally down-regulated 8 (NEDD8) is a ubiquitin-like modifier, which forms covalent conjugates on lysines of its substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 280,
                    "text": "This post-translational modification, neddylation, plays important roles in tumor cell proliferation and viability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 281,
                    "offsetInEndSection": 415,
                    "text": "Ubiquitin can form diverse polyubiquitin chains, on its seven lysines, which play important functions in various biological processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 478,
                    "text": "However, the roles of lysines in NEDD8 have not been explored."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 479,
                    "offsetInEndSection": 621,
                    "text": "Here, we generated nine NEDD8 point mutants, each with one lysine replaced by an arginine, to study the putative function of lysines in NEDD8."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 622,
                    "offsetInEndSection": 713,
                    "text": "Our experiments discover that Lys27 in NEDD8 is a critical residue for protein neddylation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 714,
                    "offsetInEndSection": 828,
                    "text": "Replacement of this residue with arginine almost completely eliminates the conjugation of NEDD8 to its substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 829,
                    "offsetInEndSection": 1013,
                    "text": "Furthermore, we find that the K27R mutant impairs NEDD8 conjugation to the E2 enzyme, which normally forms thioester bonds for further transferring NEDD8 to its ligases and substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1194,
                    "text": "Therefore, this mutation completely inhibits global protein neddylation, including neddylation of cullin family proteins, resulting in decreased activity of cullin-RING E3 ligases."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                "http://www.ncbi.nlm.nih.gov/pubmed/12660252",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                "http://www.ncbi.nlm.nih.gov/pubmed/21183718",
                "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                "http://www.ncbi.nlm.nih.gov/pubmed/17671506",
                "http://www.ncbi.nlm.nih.gov/pubmed/26055704",
                "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                "http://www.ncbi.nlm.nih.gov/pubmed/23361013"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Tn7 transposes proximal to DNA double-strand breaks and into regions where chromosomal DNA replication terminates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "We report that the bacterial transposon Tn7 can preferentially transpose into regions where chromosomal DNA replication terminates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 132,
                    "offsetInEndSection": 297,
                    "text": "DNA double-strand breaks are associated with the termination of chromosomal replication; therefore, we directly tested the effect of DNA breaks on Tn7 transposition."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 467,
                    "text": "When DNA double-strand breaks are induced at specific sites in the chromosome, Tn7 transposition is stimulated and insertions are directed proximal to the induced break."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 599,
                    "text": "The targeting preference for the terminus of replication and DNA double-strand breaks is dependent on the Tn7-encoded protein TnsE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 600,
                    "offsetInEndSection": 781,
                    "text": "The results presented in this study could also explain the previous observation that Tn7 is attracted to events associated with conjugal DNA replication during plasmid DNA transfer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Prompt repair of hydrogen peroxide-induced DNA lesions prevents catastrophic chromosomal fragmentation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Iron-dependent oxidative DNA damage in vivo by hydrogen peroxide (H2O2, HP) induces copious single-strand(ss)-breaks and base modifications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 141,
                    "offsetInEndSection": 243,
                    "text": "HP also causes infrequent double-strand DNA breaks, whose relationship to the cell killing is unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 244,
                    "offsetInEndSection": 452,
                    "text": "Since hydrogen peroxide only fragments chromosomes in growing cells, these double-strand breaks were thought to represent replication forks collapsed at direct or excision ss-breaks and to be fully reparable."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                "http://www.ncbi.nlm.nih.gov/pubmed/28720095",
                "http://www.ncbi.nlm.nih.gov/pubmed/24885373",
                "http://www.ncbi.nlm.nih.gov/pubmed/18052725",
                "http://www.ncbi.nlm.nih.gov/pubmed/18427397",
                "http://www.ncbi.nlm.nih.gov/pubmed/26351669",
                "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                "http://www.ncbi.nlm.nih.gov/pubmed/27388852",
                "http://www.ncbi.nlm.nih.gov/pubmed/24199692"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Fibrocytes are circulating mesenchymal precursors (CD45+, col 1+) recruited to fibrotic areas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 261,
                    "text": "Fibrocytes secrete profibrotic mediators including periostin; a matricellular protein that regulates cellular interactions with extracellular matrix (ECM) components."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 262,
                    "offsetInEndSection": 392,
                    "text": "In bleomycin-induced fibrosis, periostin deficiency in structural or hematopoietic cells limits development of pulmonary fibrosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 393,
                    "offsetInEndSection": 662,
                    "text": "To determine if hematopoietic-derived fibrocytes might secrete soluble factors to activate structural myofibroblast differentiation, wild-type (WT) fibroblasts were treated with conditioned medium from fibrocytes isolated from bleomycin-treated WT or periostin-/- mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 663,
                    "offsetInEndSection": 789,
                    "text": "After 24\u2009h we saw less \u03b1-smooth muscle actin expression in cells treated with conditioned medium from periostin-/- fibrocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 790,
                    "offsetInEndSection": 920,
                    "text": "Adoptive transfer of WT fibrocytes augmented lung fibrosis to a greater extent than transfer of fibrocytes from periostin-/- mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 921,
                    "offsetInEndSection": 1165,
                    "text": "In vitro analysis of fibrocytes and fibroblasts isolated from WT and periostin-/- mice treated with TGF\u03b21 or periostin demonstrated co-regulation of mesenchymal activation and beta 1 integrin as a potential receptor for periostin on fibrocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1166,
                    "offsetInEndSection": 1391,
                    "text": "Additionally, connective tissue growth factor (CTGF) mRNA expression was increased in fibrocytes treated with periostin whereas CTGF and lysl oxidase (LOX) mRNA expression was low in bleomycin-treated periostin-/- fibrocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1392,
                    "offsetInEndSection": 1557,
                    "text": "These data suggest fibrocytes may augment bleomycin-induced fibrosis via secretion of periostin and other soluble factors that promote myofibroblast differentiation."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                "http://www.ncbi.nlm.nih.gov/pubmed/27084844",
                "http://www.ncbi.nlm.nih.gov/pubmed/28790415",
                "http://www.ncbi.nlm.nih.gov/pubmed/29036538",
                "http://www.ncbi.nlm.nih.gov/pubmed/27895893",
                "http://www.ncbi.nlm.nih.gov/pubmed/26853553",
                "http://www.ncbi.nlm.nih.gov/pubmed/28203482",
                "http://www.ncbi.nlm.nih.gov/pubmed/27796346",
                "http://www.ncbi.nlm.nih.gov/pubmed/27307343",
                "http://www.ncbi.nlm.nih.gov/pubmed/28165553"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 59,
                    "text": "Long noncoding RNA dysregulation in ischemic heart failure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "BACKGROUND\nLong noncoding RNAs (lncRNAs) are non-protein coding transcripts regulating a variety of physiological and pathological functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 211,
                    "text": "However, their implication in heart failure is still largely unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 333,
                    "text": "The aim of this study is to identify and characterize lncRNAs deregulated in patients affected by ischemic heart failure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 336,
                    "offsetInEndSection": 504,
                    "text": "METHODS\nLncRNAs were profiled and validated in left ventricle biopsies of 18 patients affected by non end-stage dilated ischemic cardiomyopathy and 17 matched controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 505,
                    "offsetInEndSection": 720,
                    "text": "Further validations were performed in left ventricle samples derived from explanted hearts of end-stage heart failure patients and in a mouse model of cardiac hypertrophy, obtained by transverse aortic constriction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 721,
                    "offsetInEndSection": 801,
                    "text": "Peripheral blood mononuclear cells of heart failure patients were also analyzed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 802,
                    "offsetInEndSection": 873,
                    "text": "LncRNA distribution in the heart was assessed by in situ hybridization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 874,
                    "offsetInEndSection": 1037,
                    "text": "Function of the deregulated lncRNA was explored analyzing the expression of the neighbor mRNAs and by gene ontology analysis of the correlating coding transcripts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1040,
                    "offsetInEndSection": 1180,
                    "text": "RESULTS\nFourteen lncRNAs were significantly modulated in non end-stage heart failure patients, identifying a heart failure lncRNA signature."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                "http://www.ncbi.nlm.nih.gov/pubmed/28549783",
                "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                "http://www.ncbi.nlm.nih.gov/pubmed/26934530",
                "http://www.ncbi.nlm.nih.gov/pubmed/28061552",
                "http://www.ncbi.nlm.nih.gov/pubmed/27756784",
                "http://www.ncbi.nlm.nih.gov/pubmed/27485082"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 35,
                    "text": "Dinutuximab: first global approval."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "United Therapeutics Corporation and the National Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 188,
                    "offsetInEndSection": 286,
                    "text": "GD2 is a glycolipid found on the surface of tumour cells, which is overexpressed in neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 287,
                    "offsetInEndSection": 490,
                    "text": "Dinutuximab, an IgG1 human/mouse chimeric switch variant of murine monoclonal antibody 14G2a, binds to GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 491,
                    "offsetInEndSection": 635,
                    "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 636,
                    "offsetInEndSection": 797,
                    "text": "The marketing authorization application for dinutuximab is under regulatory review in the EU, and phase I-III development is underway in several other countries."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 798,
                    "offsetInEndSection": 1182,
                    "text": "This article summarizes the milestones in the development of dinutuximab leading to this first approval for use (in combination with granulocyte macrophage colony-stimulating factor, interleukin-2 and 13-cis retinoic acid) in the treatment of paediatric patients with high-risk neuroblastoma who achieve at least partial response to prior first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "Dinutuximab for maintenance therapy in pediatric neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 183,
                    "text": "PURPOSE\nThe pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma are reviewed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 467,
                    "text": "SUMMARY\nDinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                "http://www.ncbi.nlm.nih.gov/pubmed/25249628",
                "http://www.ncbi.nlm.nih.gov/pubmed/27814676",
                "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/28911122",
                "http://www.ncbi.nlm.nih.gov/pubmed/27587683"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Chromatin immunoprecipitation (ChIP) is an indispensable tool in the fields of epigenetics and gene regulation that isolates specific protein-DNA interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 306,
                    "text": "ChIP coupled to high throughput sequencing (ChIP-seq) is commonly used to determine the genomic location of proteins that interact with chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 307,
                    "offsetInEndSection": 431,
                    "text": "However, ChIP-seq is hampered by relatively low mapping resolution of several hundred base pairs and high background signal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 432,
                    "offsetInEndSection": 544,
                    "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 545,
                    "offsetInEndSection": 775,
                    "text": "The key distinction of the ChIP-exo methodology is the incorporation of lambda exonuclease digestion in the library preparation workflow to effectively footprint the left and right 5' DNA borders of the protein-DNA crosslink site."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 848,
                    "text": "The ChIP-exo libraries are then subjected to high throughput sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 849,
                    "offsetInEndSection": 985,
                    "text": "The resulting data can be leveraged to provide unique and ultra-high resolution insights into the functional organization of the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1138,
                    "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25249628",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 39,
                    "text": "MACE: model based analysis of ChIP-exo."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                "http://www.ncbi.nlm.nih.gov/pubmed/9876894",
                "http://www.ncbi.nlm.nih.gov/pubmed/7605803",
                "http://www.ncbi.nlm.nih.gov/pubmed/12090301",
                "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                "http://www.ncbi.nlm.nih.gov/pubmed/9726008",
                "http://www.ncbi.nlm.nih.gov/pubmed/7814031",
                "http://www.ncbi.nlm.nih.gov/pubmed/1627156"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Association of G-quadruplex forming sequences with human mtDNA deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "BACKGROUND\nMitochondrial DNA (mtDNA) deletions cause disease and accumulate during aging, yet our understanding of the molecular mechanisms underlying their formation remains rudimentary."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 188,
                    "offsetInEndSection": 443,
                    "text": "Guanine-quadruplex (GQ) DNA structures are associated with nuclear DNA instability in cancer; recent evidence indicates they can also form in mitochondrial nucleic acids, suggesting that these non-B DNA structures could be associated with mtDNA deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 551,
                    "text": "Currently, the multiple types of GQ sequences and their association with human mtDNA stability are unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 554,
                    "offsetInEndSection": 824,
                    "text": "RESULTS\nHere, we show an association between human mtDNA deletion breakpoint locations (sites where DNA ends rejoin after deletion of a section) and sequences with G-quadruplex forming potential (QFP), and establish the ability of selected sequences to form GQ in vitro."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 825,
                    "offsetInEndSection": 1073,
                    "text": "QFP contain four runs of either two or three consecutive guanines (2G and 3G, respectively), and we identified four types of QFP for subsequent analysis: intrastrand 2G, intrastrand 3G, duplex derived interstrand (ddi) 2G, and ddi 3G QFP sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1074,
                    "offsetInEndSection": 1321,
                    "text": "We analyzed the position of each motif set relative to either 5' or 3' unique mtDNA deletion breakpoints, and found that intrastrand QFP sequences, but not ddi QFP sequences, showed significant association with mtDNA deletion breakpoint locations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1322,
                    "offsetInEndSection": 1458,
                    "text": "Moreover, a large proportion of these QFP sequences occur at smaller distances to breakpoints relative to distribution-matched controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1459,
                    "offsetInEndSection": 1568,
                    "text": "The positive association of 2G QFP sequences persisted when breakpoints were divided into clinical subgroups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1569,
                    "offsetInEndSection": 1733,
                    "text": "We tested in vitro GQ formation of representative mtDNA sequences containing these 2G QFP sequences and detected robust GQ structures by UV-VIS and CD spectroscopy."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26874353",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                "http://www.ncbi.nlm.nih.gov/pubmed/28185365",
                "http://www.ncbi.nlm.nih.gov/pubmed/23692083",
                "http://www.ncbi.nlm.nih.gov/pubmed/19010924",
                "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                "http://www.ncbi.nlm.nih.gov/pubmed/28253710",
                "http://www.ncbi.nlm.nih.gov/pubmed/23761296"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 25,
                    "text": "Circular RNAs and cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Circular RNAs (circRNAs) are a type of non-coding RNA molecules that lack a 5'-terminal cap and 3'-terminal poly A tail."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 121,
                    "offsetInEndSection": 254,
                    "text": "A large number of circRNAs have been identified through biological experiments, computational methods and high-throughput sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 355,
                    "text": "CircRNA sequence composition determines if a given circRNA is exonic, intronic or retained-intronic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 356,
                    "offsetInEndSection": 470,
                    "text": "CircRNAs are more abundant and stable than linear mRNAs, and their expression is both step- and location-specific."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 471,
                    "offsetInEndSection": 571,
                    "text": "CircRNAs mediate transcriptional and post-transcriptional regulation of gene and protein expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 730,
                    "text": "CircRNAs regulate cancer development via multiple mechanisms, including miRNA sponges, modulating Wnt signaling pathway and epithelial-mesenchymal transition."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 886,
                    "text": "An in-depth study of circRNA will provide a better understanding of carcinogenesis and assist in developing clinical diagnostic and therapeutic strategies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26874353",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "The understanding of circular RNAs as special triggers in carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26874353",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Circular RNAs (circRNAs) are a large type of noncoding RNAs characterized by their circular shape resulting from covalently closed continuous loops."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                "http://www.ncbi.nlm.nih.gov/pubmed/21801775",
                "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                "http://www.ncbi.nlm.nih.gov/pubmed/16805830",
                "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                "http://www.ncbi.nlm.nih.gov/pubmed/15866516",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219461",
                "http://www.ncbi.nlm.nih.gov/pubmed/26244291",
                "http://www.ncbi.nlm.nih.gov/pubmed/11478915",
                "http://www.ncbi.nlm.nih.gov/pubmed/15629122"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Nardilysin (NRDc), a metallopeptidase of the M16 family, presents, in vitro, cleavage specificity for basic residues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 201,
                    "text": "Depending on the cell type, it is cytoplasmic, exported or cell surface associated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 202,
                    "offsetInEndSection": 352,
                    "text": "As a new receptor for heparin-binding EGF-like growth factor (HB-EGF), NRDc was recently shown to be involved in cellular migration and proliferation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 499,
                    "text": "Since for those processes its enzymatic activity is not required, it is now evident that nardilysin fulfills at least two distinct functions, i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 500,
                    "offsetInEndSection": 536,
                    "text": "an HB-EGF modulator and a peptidase."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Nardilysin facilitates complex formation between mitochondrial malate dehydrogenase and citrate synthase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 221,
                    "text": "Gel filtration chromatography showed that nardilysin activity in a rat testis or rat brain extract exhibited an apparent molecular weight of approximately 300 kDa compared to approximately 187 kDa for the purified enzyme."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 351,
                    "text": "The addition of purified nardilysin to a rat brain extract, but not to an E. coli extract, produced the higher molecular species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 562,
                    "text": "The addition of a GST fusion protein containing the acidic domain of nardilysin eliminated the higher molecular weight nardilysin forms, suggesting that oligomerization involves the acidic domain of nardilysin."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                "http://www.ncbi.nlm.nih.gov/pubmed/17158278",
                "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                "http://www.ncbi.nlm.nih.gov/pubmed/18579028",
                "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                "http://www.ncbi.nlm.nih.gov/pubmed/9699213",
                "http://www.ncbi.nlm.nih.gov/pubmed/19475629",
                "http://www.ncbi.nlm.nih.gov/pubmed/11089393",
                "http://www.ncbi.nlm.nih.gov/pubmed/24398852",
                "http://www.ncbi.nlm.nih.gov/pubmed/20381206"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Utility of QuantiFERON\u00ae-TB Gold test in diagnosis and management of suspected tubercular uveitis in India."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "The tuberculin skin test, used to detect latent systemic tuberculosis (TB), has its limitations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 97,
                    "offsetInEndSection": 226,
                    "text": "The utility of interferon-gamma assays, found useful in the diagnosis of latent TB, is still unestablished in tubercular uveitis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 227,
                    "offsetInEndSection": 380,
                    "text": "We present the results of QuantiFERON(\u00ae)-TB Gold (QFT-G) test and its relevance in the diagnosis and management of suspected tubercular uveitis in India."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 588,
                    "text": "All suspected tubercular uveitis patients seen at our uveitis clinic between October 2006 and June 2008 who underwent relevant blood investigations, chest X-rays, Mantoux tests and QFT-G tests were included."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 589,
                    "offsetInEndSection": 669,
                    "text": "Clinical profile, systemic correlation and outcome with treatment were analysed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 670,
                    "offsetInEndSection": 738,
                    "text": "Fifty suspected tubercular uveitis patients underwent QFT-G testing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 739,
                    "offsetInEndSection": 803,
                    "text": "The age range of the patients was 6-55 years (mean 32.66 years)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 804,
                    "offsetInEndSection": 886,
                    "text": "Seven patients presented with active and three with a past history of systemic TB."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 887,
                    "offsetInEndSection": 930,
                    "text": "The QFT-G test was positive in 29 patients."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
                "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card\u2122."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "The indicating FTA elute micro card\u2122 has been developed to collect and stabilize the nucleic acid in biological samples and is widely used in human and veterinary medicine and other disciplines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 292,
                    "text": "This card is not recommended for protein analyses, since surface treatment may denature proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 473,
                    "text": "We studied the ability to analyse proteins in human plasma and vaginal fluid as applied to the indicating FTA elute micro card\u2122 using the sensitive proximity extension assay (PEA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 655,
                    "offsetInEndSection": 737,
                    "text": "Washing and protein elution protocols were compared to identify an optimal method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 862,
                    "text": "Liquid-based cytology samples showed a lower number of proteins above LOD than FTA cards with vaginal fluid samples applied."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1038,
                    "text": "Our results demonstrate that samples applied to the indicating FTA elute micro card\u2122 are amendable to protein analyses, given that a sensitive protein detection assay is used."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1039,
                    "offsetInEndSection": 1149,
                    "text": "The results imply that biological samples applied to FTA cards can be used for DNA, RNA and protein detection."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                "http://www.ncbi.nlm.nih.gov/pubmed/23804334",
                "http://www.ncbi.nlm.nih.gov/pubmed/10096530",
                "http://www.ncbi.nlm.nih.gov/pubmed/17620265",
                "http://www.ncbi.nlm.nih.gov/pubmed/12038658"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nThere has been recent interest in the possible role of reperfusion-induced inflammation with neuronal injury after stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 282,
                    "text": "Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 384,
                    "text": "The purpose of the current clinical trial was to evaluate the use of enlimomab after ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 546,
                    "text": "METHODS\nA total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 579,
                    "text": "Treatment was given over 5 days."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 580,
                    "offsetInEndSection": 729,
                    "text": "Patients were evaluated at baseline and on days 5 and 90 after initiation of treatment; long-term assessments were carried out after 6 and 12 months."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 730,
                    "offsetInEndSection": 907,
                    "text": "The primary efficacy endpoint was the response to therapy at 90 days on the Modified Rankin Scale; other endpoints included Barthel Index (BI) and NIH Stroke Scale and survival."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 910,
                    "offsetInEndSection": 1036,
                    "text": "RESULTS\nAt day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1037,
                    "offsetInEndSection": 1151,
                    "text": "Fewer patients had symptom-free recovery on enlimomab than placebo (p = 0.004), and more died (22.2 versus 16.2%)."
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                "http://www.ncbi.nlm.nih.gov/pubmed/21880665",
                "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                "http://www.ncbi.nlm.nih.gov/pubmed/27653967",
                "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                "http://www.ncbi.nlm.nih.gov/pubmed/28596937",
                "http://www.ncbi.nlm.nih.gov/pubmed/19299492",
                "http://www.ncbi.nlm.nih.gov/pubmed/19373675",
                "http://www.ncbi.nlm.nih.gov/pubmed/25105153"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "Retinal Gene Therapy: Current Progress and Future Prospects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Clinical trials treating inherited retinal dystrophy caused by RPE65 mutations had put retinal gene therapy at the forefront of gene therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 284,
                    "text": "Both successes and limitations in these clinical trials have fueled developments in gene vectors, which continue to further advance the field."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 285,
                    "offsetInEndSection": 530,
                    "text": "These novel gene vectors aim to more safely and efficiently transduce retinal cells, expand the gene packaging capacity of AAV, and utilize new strategies to correct the varying mechanisms of dysfunction found with inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 691,
                    "text": "With recent clinical trials and numerous pre-clinical studies utilizing these novel vectors, the future of ocular gene therapy continues to hold vast potential."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "[Specific gene therapy for hereditary retinal dystrophies - an update]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Treatment possibilities based on specific gene therapy strategies have become reality for a small number of patients with hereditary retinal dystrophies and are currently under investigation in several clinical trials worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 229,
                    "offsetInEndSection": 315,
                    "text": "The most advanced studies are for patients suffering from mutations in the RPE65 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 316,
                    "offsetInEndSection": 437,
                    "text": "In addition, studies are ongoing for patients with disease causing mutations in the MERTK, REP1, ABCA4, or Myosin7A gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 438,
                    "offsetInEndSection": 650,
                    "text": "Depending on the size of the gene copy to be transferred, two vectors are currently used in clinical trials: vectors based on adeno-associated virus (AAV) or on lentivirus (equine infectious anaemia virus, EIAV)."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                "http://www.ncbi.nlm.nih.gov/pubmed/27072975",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                "http://www.ncbi.nlm.nih.gov/pubmed/12468781",
                "http://www.ncbi.nlm.nih.gov/pubmed/9305321",
                "http://www.ncbi.nlm.nih.gov/pubmed/23600725"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Efficacy of citicoline as an acute stroke treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "Citicoline (cytidine-5'-diphosphocholine or CDP-choline) is a precursor essential for the synthesis of phosphatidylcholine, one of the cell membrane components that is degraded during cerebral ischemia to free fatty acids and free radicals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 241,
                    "offsetInEndSection": 466,
                    "text": "Animal studies suggest that citicoline may protect cell membranes by accelerating resynthesis of phospholipids and suppressing the release of free fatty acids, stabilizing cell membranes, and reducing free radical generation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 467,
                    "offsetInEndSection": 620,
                    "text": "Numerous experimental stroke studies with citicoline have shown improved outcome and reduced infarct size in both ischemic and hemorrhagic stroke models."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 621,
                    "offsetInEndSection": 776,
                    "text": "Citicoline has been studied worldwide in both ischemic and hemorrhagic clinical stroke with excellent safety and possibly efficacy found in several trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 777,
                    "offsetInEndSection": 1015,
                    "text": "A meta-analysis of four randomized US clinical citicoline trials concluded that treatment with oral citicoline within the first 24 h after a moderate to severe stroke is safe and increases the probability of complete recovery at 3 months."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1016,
                    "offsetInEndSection": 1129,
                    "text": "Citicoline clinical efficacy trials are now continuing outside of the US in both ischemic and hemorrhagic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1130,
                    "offsetInEndSection": 1208,
                    "text": "A citicoline supplement is now available from several sources on the internet."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "BACKGROUND\nCiticoline is a drug approved for the treatment of acute ischemic stroke."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                "http://www.ncbi.nlm.nih.gov/pubmed/11386757",
                "http://www.ncbi.nlm.nih.gov/pubmed/27063404",
                "http://www.ncbi.nlm.nih.gov/pubmed/14550642",
                "http://www.ncbi.nlm.nih.gov/pubmed/11334717"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "A new gene with sequence and structural similarity to the gene encoding human lysyl oxidase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "We have isolated a number of recombinant clones from a human skin fibroblast cDNA library that contain extensive sequence homology to several coding domains within the human lysyl oxidase mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 194,
                    "offsetInEndSection": 296,
                    "text": "Using one of these lysyl oxidase-like cDNAs, we obtained several overlapping genomic DNA recombinants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 297,
                    "offsetInEndSection": 488,
                    "text": "Restriction mapping and DNA sequence analysis revealed that the complete sequence of the lysyl oxidase-like mRNA was encoded by seven exons distributed throughout 25 kilobases of genomic DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 556,
                    "text": "Exons 2-6 encoded the region of greatest homology to lysyl oxidase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 557,
                    "offsetInEndSection": 687,
                    "text": "The size of these five exons, moreover, was exactly the same as the size of the corresponding exons within the lysyl oxidase gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 688,
                    "offsetInEndSection": 822,
                    "text": "Northern blot analysis also revealed the concomitant appearance of lysyl oxidase and lysyl oxidase-like mRNA in several human tissues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 987,
                    "text": "It appears therefore that the genes encoding lysyl oxidase and a lysyl oxidase-like protein share a common evolutionary origin and may also be functionally related."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "The lysyl oxidase-like 2 (LOXL2) protein is a human paralogue of lysyl oxidase (LOX) that functions as an amine oxidase for formation of lysine-derived cross-links found in collagen and elastin."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                "http://www.ncbi.nlm.nih.gov/pubmed/22675198",
                "http://www.ncbi.nlm.nih.gov/pubmed/17185363",
                "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                "http://www.ncbi.nlm.nih.gov/pubmed/26230285",
                "http://www.ncbi.nlm.nih.gov/pubmed/26990020",
                "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                "http://www.ncbi.nlm.nih.gov/pubmed/26781874"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Growth Differentiation Factor 15 as a Novel Biomarker for Metformin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 61,
                    "text": "OBJECTIVE\nMetformin is a commonly used glucose-lowering drug."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 62,
                    "offsetInEndSection": 159,
                    "text": "However, apart from glycemic measures, no biomarker for its presence or dose has been identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 374,
                    "text": "RESEARCH DESIGN AND METHODS\nA total of 237 biomarkers were assayed in baseline serum from 8,401 participants (2,317 receiving metformin) in the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 375,
                    "offsetInEndSection": 444,
                    "text": "Regression models were used to identify biomarkers for metformin use."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 698,
                    "text": "RESULTS\nGrowth differentiation factor 15 (GDF15) was strongly linked to metformin, such that the odds of metformin use per SD increase in level varied from 3.73 (95% CI 3.40, 4.09) to 3.94 (95% CI 3.59, 4.33) depending on the other included variables."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 773,
                    "text": "For the remaining 25 linked biomarkers, the odds ranged from 0.71 to 1.24."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 860,
                    "text": "A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P < 0.0001)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1010,
                    "text": "CONCLUSIONS\nGDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                "http://www.ncbi.nlm.nih.gov/pubmed/28243993",
                "http://www.ncbi.nlm.nih.gov/pubmed/21247220",
                "http://www.ncbi.nlm.nih.gov/pubmed/22815318",
                "http://www.ncbi.nlm.nih.gov/pubmed/25645999",
                "http://www.ncbi.nlm.nih.gov/pubmed/28942404",
                "http://www.ncbi.nlm.nih.gov/pubmed/28164324",
                "http://www.ncbi.nlm.nih.gov/pubmed/28782884",
                "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                "http://www.ncbi.nlm.nih.gov/pubmed/20392977"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 135,
                    "text": "Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of low-grade or follicular non-Hodgkin's lymphoma (NHL)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 252,
                    "text": "Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 253,
                    "offsetInEndSection": 395,
                    "text": "Recently, however, tumor lysis syndrome (TLS) resulting from rituximab has been reported in a patient with chronic lymphocytic leukemia (CLL)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 396,
                    "offsetInEndSection": 449,
                    "text": "We herein present two cases of rituximab-induced TLS."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 561,
                    "text": "The first case occurred in a patient with high-grade NHL, while the second case occurred in a patient with CLL."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 562,
                    "offsetInEndSection": 647,
                    "text": "We also present a summary of the literature regarding TLS induced by immunotherapies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Physicians' perceptions and practices regarding patient reports of multiple chemical sensitivity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Ninety physicians practicing in the state of Virginia USA completed a mail survey regarding Multiple Chemical Sensitivity (MCS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 319,
                    "text": "Survey questions addressed demographics; familiarity with MCS; etiology; overlapping conditions; accommodations made for patients and practices regarding evaluation, treatment, and referral."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                "http://www.ncbi.nlm.nih.gov/pubmed/24845676",
                "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                "http://www.ncbi.nlm.nih.gov/pubmed/21311564",
                "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                "http://www.ncbi.nlm.nih.gov/pubmed/21641882",
                "http://www.ncbi.nlm.nih.gov/pubmed/27160911",
                "http://www.ncbi.nlm.nih.gov/pubmed/26292731"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 53,
                    "text": "Oncogenes create a unique landscape of fragile sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Recurrent genomic instability in cancer is attributed to positive selection and/or the sensitivity of specific genomic regions to breakage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 140,
                    "offsetInEndSection": 296,
                    "text": "Among these regions are fragile sites (FSs), genomic regions sensitive to replication stress conditions induced by the DNA polymerase inhibitor aphidicolin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 297,
                    "offsetInEndSection": 388,
                    "text": "However, the basis for the majority of cancer genomic instability hotspots remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 492,
                    "text": "Aberrant oncogene expression induces replication stress, leading to DNA breaks and genomic instability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 493,
                    "offsetInEndSection": 697,
                    "text": "Here we map the cytogenetic locations of oncogene-induced FSs and show that in the same cells, each oncogene creates a unique fragility landscape that only partially overlaps with aphidicolin-induced FSs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 698,
                    "offsetInEndSection": 806,
                    "text": "Oncogene-induced FSs colocalize with cancer breakpoints and large genes, similar to aphidicolin-induced FSs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 807,
                    "offsetInEndSection": 1012,
                    "text": "The observed plasticity in the fragility landscape of the same cell type following oncogene expression highlights an additional level of complexity in the molecular basis for recurrent fragility in cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Genomic instability--an evolving hallmark of cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Genomic instability is a characteristic of most cancers."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                "http://www.ncbi.nlm.nih.gov/pubmed/26595274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                "http://www.ncbi.nlm.nih.gov/pubmed/27810583",
                "http://www.ncbi.nlm.nih.gov/pubmed/19493899",
                "http://www.ncbi.nlm.nih.gov/pubmed/21855309",
                "http://www.ncbi.nlm.nih.gov/pubmed/25231926",
                "http://www.ncbi.nlm.nih.gov/pubmed/26081994"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Large-scale genomic analyses of ancient human populations have become feasible partly due to refined sampling methods."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 255,
                    "text": "The inner part of petrous bones and the cementum layer in teeth roots are currently recognized as the best substrates for such research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 434,
                    "text": "We present a comparative analysis of DNA preservation in these two substrates obtained from the same human skulls, across a range of different ages and preservation environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 617,
                    "text": "Both substrates display significantly higher endogenous DNA content (average of 16.4% and 40.0% for teeth and petrous bones, respectively) than parietal skull bone (average of 2.2%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 618,
                    "offsetInEndSection": 723,
                    "text": "Despite sample-to-sample variation, petrous bone overall performs better than tooth cementum (p = 0.001)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 906,
                    "text": "This difference, however, is driven largely by a cluster of viking skeletons from one particular locality, showing relatively poor molecular tooth preservation (<10% endogenous DNA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 907,
                    "offsetInEndSection": 995,
                    "text": "In the remaining skeletons there is no systematic difference between the two substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 996,
                    "offsetInEndSection": 1150,
                    "text": "A crude preservation (good/bad) applied to each sample prior to DNA-extraction predicted the above/below 10% endogenous DNA threshold in 80% of the cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1151,
                    "offsetInEndSection": 1340,
                    "text": "Interestingly, we observe signficantly higher levels of cytosine to thymine deamination damage and lower proportions of mitochondrial/nuclear DNA in petrous bone compared to tooth cementum."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                "http://www.ncbi.nlm.nih.gov/pubmed/11269499",
                "http://www.ncbi.nlm.nih.gov/pubmed/25800735",
                "http://www.ncbi.nlm.nih.gov/pubmed/19924226",
                "http://www.ncbi.nlm.nih.gov/pubmed/19683670",
                "http://www.ncbi.nlm.nih.gov/pubmed/9111348",
                "http://www.ncbi.nlm.nih.gov/pubmed/16314266"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Genome-wide identification of zero nucleotide recursive splicing in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points--5' splice sites recreated after splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 354,
                    "text": "Recursive splicing was first identified in the Drosophila Ultrabithorax (Ubx) gene and only three additional Drosophila genes have since been experimentally shown to undergo recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 355,
                    "offsetInEndSection": 561,
                    "text": "Here we identify 197 zero nucleotide exon ratchet points in 130 introns of 115 Drosophila genes from total RNA sequencing data generated from developmental time points, dissected tissues and cultured cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 562,
                    "offsetInEndSection": 709,
                    "text": "The sequential nature of recursive splicing was confirmed by identification of lariat introns generated by splicing to and from the ratchet points."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 710,
                    "offsetInEndSection": 922,
                    "text": "We also show that recursive splicing is a constitutive process, that depletion of U2AF inhibits recursive splicing, and that the sequence and function of ratchet points are evolutionarily conserved in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 923,
                    "offsetInEndSection": 1037,
                    "text": "Finally, we identify four recursively spliced human genes, one of which is also recursively spliced in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1038,
                    "offsetInEndSection": 1226,
                    "text": "Together, these results indicate that recursive splicing is commonly used in Drosophila, occurs in humans, and provides insight into the mechanisms by which some large introns are removed."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Many genes with important roles in development and disease contain exceptionally long introns, but special mechanisms for their expression have not been investigated."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                "http://www.ncbi.nlm.nih.gov/pubmed/26918",
                "http://www.ncbi.nlm.nih.gov/pubmed/906929",
                "http://www.ncbi.nlm.nih.gov/pubmed/9260463",
                "http://www.ncbi.nlm.nih.gov/pubmed/8116",
                "http://www.ncbi.nlm.nih.gov/pubmed/9524359",
                "http://www.ncbi.nlm.nih.gov/pubmed/2890532",
                "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                "http://www.ncbi.nlm.nih.gov/pubmed/8096378",
                "http://www.ncbi.nlm.nih.gov/pubmed/7546771"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Skin lysyl oxidase activity is not rate limiting for collagen crosslinking in the glucocorticoid-treated rat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 181,
                    "text": "Lysyl oxidase activity in the skin of rats receiving triamcinolone diacetate (12 mg/kg) for three consecutive days was decreased by sixty-four percent as compared to control values."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 288,
                    "text": "A decrease of lysyl oxidase activity was observed twelve hours after the initial glucocorticoid injection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 289,
                    "offsetInEndSection": 411,
                    "text": "The decreased lysyl oxidase activity was accompanied by a forty-nine percent decrease of acetic acid extractable collagen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 412,
                    "offsetInEndSection": 555,
                    "text": "There was also a forty-two percent decrease in the alpha/beta ratio of the acetic acid soluble skin collagen of glucocorticoid-treated animals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 777,
                    "text": "These data indicate that although skin lysyl oxidase activity is decreased by glucocorticoid treatment, the crosslinking of acid extracted collagen as measured by the alpha/beta ratio and collagen solubility is increased."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 778,
                    "offsetInEndSection": 917,
                    "text": "Accordingly lysyl oxidase activity is not rate limiting for collagen crosslink formation in the skins of rats treated with glucocorticoids."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Biosynthesis of collagen crosslinks: increased activity of purified lysyl oxidase with reconstituted collagen fibrils."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Lysyl oxidase catalyzes the formation of crosslinking aldehydes in collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 89,
                    "offsetInEndSection": 407,
                    "text": "This report demonstrates that the enzyme has high activity with collagen precipitated as native fibrils, an apparent K(m) of 0.95 muM, and low activity toward either soluble forms such as denatured collagen, isolated alpha chain, or isolated alpha1-CBl peptide, or precipitated collagen fibrils after pepsin treatment."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                "http://www.ncbi.nlm.nih.gov/pubmed/16967378",
                "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                "http://www.ncbi.nlm.nih.gov/pubmed/24771728",
                "http://www.ncbi.nlm.nih.gov/pubmed/20494064",
                "http://www.ncbi.nlm.nih.gov/pubmed/17244925",
                "http://www.ncbi.nlm.nih.gov/pubmed/15854093",
                "http://www.ncbi.nlm.nih.gov/pubmed/25332648",
                "http://www.ncbi.nlm.nih.gov/pubmed/23989817",
                "http://www.ncbi.nlm.nih.gov/pubmed/11845875"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 72,
                    "text": "A new cable-tie-based sternal closure device: infectious considerations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "OBJECTIVES\nTo determine the difference in sternal infection and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 433,
                    "text": "METHODS\nThe sternal ZipFix\u2122 (ZF) system consists of a biocompatible poly-ether-ether-ketone (PEEK) cable-tie that surrounds the sternum through the intercostal space and provides a large implant-to-bone contact."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 551,
                    "text": "Between 1 February 2011 and 31 January 2012, 680 cardiac operations were performed via sternotomy at our institution."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 789,
                    "text": "After the exclusion of operations for active endocarditis and early mortality within 7 days, 95 patients were exclusively closed with ZF and could be compared with 498 who were closed with conventional wires (CWs) during the same period."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 790,
                    "offsetInEndSection": 986,
                    "text": "A multivariable logistic regression analysis, including body mass index, renal impairment and emergency as suspected confounders and inverse propensity weights was performed on the infection rate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1099,
                    "text": "RESULTS\nTotal infection rate was 6.1%, with a total of 36 diagnosed sternal infections (5 in ZF and 31 in CW)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1100,
                    "offsetInEndSection": 1286,
                    "text": "Comparing ZF with CW with regard to sternal infection, there is no statistically significant difference related to the device (odds ratio: 0.067, confidence interval: 0.04-9.16, P=0.72)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1466,
                    "offsetInEndSection": 1559,
                    "text": "No sternal instability was observed with the ZF device, unlike 4/31 patients in the CW group."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1560,
                    "offsetInEndSection": 1668,
                    "text": "The overall operation time is reduced by 11 min in the ZF group with identical perfusion and clamping times."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                "http://www.ncbi.nlm.nih.gov/pubmed/25810254",
                "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                "http://www.ncbi.nlm.nih.gov/pubmed/25404134",
                "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                "http://www.ncbi.nlm.nih.gov/pubmed/24135681",
                "http://www.ncbi.nlm.nih.gov/pubmed/23728303"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "The functional importance of gene enhancers in regulated gene expression is well established."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 94,
                    "offsetInEndSection": 289,
                    "text": "In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 290,
                    "offsetInEndSection": 404,
                    "text": "However, it has remained unclear whether these eRNAs are functional or merely a reflection of enhancer activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 405,
                    "offsetInEndSection": 608,
                    "text": "Here we report that in human breast cancer cells 17\u03b2-oestradiol (E2)-bound oestrogen receptor \u03b1 (ER-\u03b1) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 609,
                    "offsetInEndSection": 843,
                    "text": "These induced eRNAs, as functional transcripts, seem to exert important roles for the observed ligand-dependent induction of target coding genes, increasing the strength of specific enhancer-promoter looping initiated by ER-\u03b1 binding."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 844,
                    "offsetInEndSection": 1059,
                    "text": "Cohesin, present on many ER-\u03b1-regulated enhancers even before ligand treatment, apparently contributes to E2-dependent gene activation, at least in part by stabilizing E2/ER-\u03b1/eRNA-induced enhancer-promoter looping."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1060,
                    "offsetInEndSection": 1177,
                    "text": "Our data indicate that eRNAs are likely to have important functions in many regulated programs of gene transcription."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "A novel virus-inducible enhancer of the interferon-\u03b2 gene with tightly linked promoter and enhancer activities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Long-range enhancers of transcription are a key component of the genomic regulatory architecture."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115162",
                "http://www.ncbi.nlm.nih.gov/pubmed/23031510",
                "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                "http://www.ncbi.nlm.nih.gov/pubmed/22358840"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Recent structural studies on Dom34/aPelota and Hbs1/aEF1\u03b1: important factors for solving general problems of ribosomal stall in translation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "In the translation process, translating ribosomes usually move on an mRNA until they reach the stop codon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 170,
                    "text": "However, when ribosomes translate an aberrant mRNA, they stall."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 270,
                    "text": "Then, ribosomes are rescued from the aberrant mRNA, and the aberrant mRNA is subsequently degraded."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 398,
                    "text": "In eukaryotes, Pelota (Dom34 in yeast) and Hbs1 are responsible for solving general problems of ribosomal stall in translation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 521,
                    "text": "In archaea, aPelota and aEF1\u03b1, homologous to Pelota and Hbs1, respectively, are considered to be involved in that process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 522,
                    "offsetInEndSection": 626,
                    "text": "In recent years, great progress has been made in determining structures of Dom34/aPelota and Hbs1/aEF1\u03b1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 627,
                    "offsetInEndSection": 771,
                    "text": "In this review, we focus on the functional roles of Dom34/aPelota and Hbs1/aEF1\u03b1 in ribosome rescue, based on recent structural studies of them."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 772,
                    "offsetInEndSection": 833,
                    "text": "We will also present questions to be answered by future work."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Yeast dom34 mutants are defective in multiple developmental pathways and exhibit decreased levels of polyribosomes."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                "http://www.ncbi.nlm.nih.gov/pubmed/26233476",
                "http://www.ncbi.nlm.nih.gov/pubmed/23009808",
                "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                "http://www.ncbi.nlm.nih.gov/pubmed/26283469",
                "http://www.ncbi.nlm.nih.gov/pubmed/18954601",
                "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                "http://www.ncbi.nlm.nih.gov/pubmed/12193731"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Chemokines mediate diverse fundamental biological processes, including combating infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 92,
                    "offsetInEndSection": 240,
                    "text": "Multiple chemokines are expressed at the site of infection; thus chemokine synergy by heterodimer formation may play a role in determining function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 241,
                    "offsetInEndSection": 353,
                    "text": "Chemokine function involves interactions with G-protein-coupled receptors and sulfated glycosaminoglycans (GAG)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 354,
                    "offsetInEndSection": 460,
                    "text": "However, very little is known regarding heterodimer structural features and receptor and GAG interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 802,
                    "text": "Solution nuclear magnetic resonance (NMR) and molecular dynamics characterization of platelet-derived chemokine CXCL7 heterodimerization with chemokines CXCL1, CXCL4, and CXCL8 indicated that packing interactions promote CXCL7-CXCL1 and CXCL7-CXCL4 heterodimers, and electrostatic repulsive interactions disfavor the CXCL7-CXCL8 heterodimer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 803,
                    "offsetInEndSection": 976,
                    "text": "As characterizing the native heterodimer is challenging due to interference from monomers and homodimers, we engineered a \"trapped\" disulfide-linked CXCL7-CXCL1 heterodimer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 977,
                    "offsetInEndSection": 1171,
                    "text": "NMR and modeling studies indicated that GAG heparin binding to the heterodimer is distinctly different from the CXCL7 monomer and that the GAG-bound heterodimer is unlikely to bind the receptor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1172,
                    "offsetInEndSection": 1253,
                    "text": "Interestingly, the trapped heterodimer was highly active in a Ca2+ release assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1254,
                    "offsetInEndSection": 1374,
                    "text": "These data collectively suggest that GAG interactions play a prominent role in determining heterodimer function in vivo."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18503142",
                "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                "http://www.ncbi.nlm.nih.gov/pubmed/16252251",
                "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                "http://www.ncbi.nlm.nih.gov/pubmed/20515676",
                "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                "http://www.ncbi.nlm.nih.gov/pubmed/26558786",
                "http://www.ncbi.nlm.nih.gov/pubmed/16352308",
                "http://www.ncbi.nlm.nih.gov/pubmed/17550854"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Overwhelming evidence indicates that cancer is a genetic disease caused by the accumulation of mutations in oncogenes and tumor suppressor genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 315,
                    "text": "It is also increasingly apparent, however, that cancer depends not only on mutations in these coding genes but also on alterations in the large class of non-coding RNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 316,
                    "offsetInEndSection": 510,
                    "text": "Here, we report that one such long non-coding RNA, TRPM2-AS, an antisense transcript of TRPM2, which encodes an oxidative stress-activated ion channel, is overexpressed in prostate cancer (PCa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 511,
                    "offsetInEndSection": 714,
                    "text": "The high expression of TRPM2-AS and its related gene signature were found to be linked to poor clinical outcome, with the related gene signature working also independently of the patient's Gleason score."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 715,
                    "offsetInEndSection": 1012,
                    "text": "Mechanistically, TRPM2-AS knockdown led to PCa cell apoptosis, with a transcriptional profile that indicated an unbearable increase in cellular stress in the dying cells, which was coupled to cell cycle arrest, an increase in intracellular hydrogen peroxide and activation of the sense TRPM2 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24931166",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1013,
                    "offsetInEndSection": 1464,
                    "text": "Moreover, targets of existing drugs and treatments were found to be consistently associated with high TRPM2-AS levels in both targeted cells and patients, ultimately suggesting that the measurement of the expression levels of TRPM2-AS allows not only for the early identification of aggressive PCa tumors, but also identifies a subset of at-risk patients who would benefit from currently available, but mostly differently purposed, therapeutic agents."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "TRPM2 SNP genotype previously associated with susceptibility to Rhodococcus equi pneumonia in Quarter Horse foals displays differential gene expression identified using RNA-Seq."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 153,
                    "text": "BACKGROUND\nRhodococcus equi (R. equi) is an intracellular bacterium that affects young foals and immuno-compromised individuals causing severe pneumonia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 269,
                    "text": "Currently, the genetic mechanisms that confer susceptibility and/or resistance to R. equi are not fully understood."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                "http://www.ncbi.nlm.nih.gov/pubmed/28239447",
                "http://www.ncbi.nlm.nih.gov/pubmed/27355570",
                "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                "http://www.ncbi.nlm.nih.gov/pubmed/27544075",
                "http://www.ncbi.nlm.nih.gov/pubmed/27228275",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                "http://www.ncbi.nlm.nih.gov/pubmed/28328129",
                "http://www.ncbi.nlm.nih.gov/pubmed/27876396"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Potential mechanisms of Zika-linked microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "A recent outbreak of Zika virus (ZIKV) in Brazil is associated with microcephaly in infants born of infected mothers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 253,
                    "text": "As this pandemic spreads, rapid scientific investigation is shedding new light on how prenatal infection with ZIKV causes microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 525,
                    "text": "In this analysis we provide an overview of both microcephaly and ZIKV, explore the connection between prenatal ZIKV infection and microcephaly, and highlight recent insights into how prenatal ZIKV infection depletes the pool of neural progenitors in the developing brain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 555,
                    "offsetInEndSection": 655,
                    "text": "doi: 10.1002/wdev.273 For further resources related to this article, please visit the WIREs website."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "A single mutation in the prM protein of Zika virus contributes to fetal microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Zika virus (ZIKV) has evolved into a global health threat because of its unexpected causal link to microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 244,
                    "text": "Phylogenetic analysis reveals that contemporary epidemic strains have accumulated multiple substitutions from their Asian ancestor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 558,
                    "text": "Here we show that a single serine-to-asparagine substitution [Ser139\u2192Asn139 (S139N)] in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs) and led to more severe microcephaly in the mouse fetus, as well as higher mortality rates in neonatal mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 742,
                    "text": "Evolutionary analysis indicates that the S139N substitution arose before the 2013 outbreak in French Polynesia and has been stably maintained during subsequent spread to the Americas."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                "http://www.ncbi.nlm.nih.gov/pubmed/8360667",
                "http://www.ncbi.nlm.nih.gov/pubmed/24228241",
                "http://www.ncbi.nlm.nih.gov/pubmed/25747558",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822120",
                "http://www.ncbi.nlm.nih.gov/pubmed/22026259",
                "http://www.ncbi.nlm.nih.gov/pubmed/22883936",
                "http://www.ncbi.nlm.nih.gov/pubmed/20674843"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "VariSNP, a benchmark database for variations from dbSNP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "For development and evaluation of methods for predicting the effects of variations, benchmark datasets are needed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 264,
                    "text": "Some previously developed datasets are available for this purpose, but newer and larger benchmark sets for benign variants have largely been missing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 306,
                    "text": "VariSNP datasets are selected from dbSNP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 307,
                    "offsetInEndSection": 473,
                    "text": "These subsets were filtered against disease-related variants in the ClinVar, UniProtKB/Swiss-Prot, and PhenCode databases, to identify neutral or nonpathogenic cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 594,
                    "text": "All variant descriptions include mapping to reference sequences on chromosomal, genomic, coding DNA, and protein levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 595,
                    "offsetInEndSection": 729,
                    "text": "The datasets will be updated with automated scripts on a regular basis and are freely available at http://structure.bmc.lu.se/VariSNP."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "PhenCode: connecting ENCODE data with mutations and phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "PhenCode (Phenotypes for ENCODE; http://www.bx.psu.edu/phencode) is a collaborative, exploratory project to help understand phenotypes of human mutations in the context of sequence and functional data from genome projects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 223,
                    "offsetInEndSection": 461,
                    "text": "Currently, it connects human phenotype and clinical data in various locus-specific databases (LSDBs) with data on genome sequences, evolutionary history, and function from the ENCODE project and other resources in the UCSC Genome Browser."
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                "http://www.ncbi.nlm.nih.gov/pubmed/15474306",
                "http://www.ncbi.nlm.nih.gov/pubmed/15362956",
                "http://www.ncbi.nlm.nih.gov/pubmed/25538045",
                "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                "http://www.ncbi.nlm.nih.gov/pubmed/27215607",
                "http://www.ncbi.nlm.nih.gov/pubmed/19950647",
                "http://www.ncbi.nlm.nih.gov/pubmed/27639109"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Ultrasensitive proteome analysis using paramagnetic bead technology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "In order to obtain a systems-level understanding of a complex biological system, detailed proteome information is essential."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 125,
                    "offsetInEndSection": 304,
                    "text": "Despite great progress in proteomics technologies, thorough interrogation of the proteome from quantity-limited biological samples is hampered by inefficiencies during processing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 459,
                    "text": "To address these challenges, here we introduce a novel protocol using paramagnetic beads, termed Single-Pot Solid-Phase-enhanced Sample Preparation (SP3)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 460,
                    "offsetInEndSection": 698,
                    "text": "SP3 provides a rapid and unbiased means of proteomic sample preparation in a single tube that facilitates ultrasensitive analysis by outperforming existing protocols in terms of efficiency, scalability, speed, throughput, and flexibility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 927,
                    "text": "To illustrate these benefits, characterization of 1,000 HeLa cells and single Drosophila embryos is used to establish that SP3 provides an enhanced platform for profiling proteomes derived from sub-microgram amounts of material."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 928,
                    "offsetInEndSection": 1124,
                    "text": "These data present a first view of developmental stage-specific proteome dynamics in Drosophila at a single-embryo resolution, permitting characterization of inter-individual expression variation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1125,
                    "offsetInEndSection": 1330,
                    "text": "Together, the findings of this work position SP3 as a superior protocol that facilitates exciting new directions in multiple areas of proteomics ranging from developmental biology to clinical applications."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Efficient and reproducible sample preparation is a prerequisite for any robust and sensitive quantitative bottom-up proteomics workflow."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                "http://www.ncbi.nlm.nih.gov/pubmed/28029156",
                "http://www.ncbi.nlm.nih.gov/pubmed/27856734",
                "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                "http://www.ncbi.nlm.nih.gov/pubmed/23218444",
                "http://www.ncbi.nlm.nih.gov/pubmed/21684744",
                "http://www.ncbi.nlm.nih.gov/pubmed/19144712"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 234,
                    "text": "Extensive prior research focused on somatic copy-number alterations (SCNAs) affecting cancer genes, yet the extent to which recurrent SCNAs exert their influence through rearrangement of cis-regulatory elements (CREs) remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 476,
                    "text": "Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 477,
                    "offsetInEndSection": 589,
                    "text": "Analysis of 7,416 cancer genomes uncovered several pan-cancer candidate genes, including IRS4, SMARCA1 and TERT."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 590,
                    "offsetInEndSection": 750,
                    "text": "We demonstrate that IRS4 overexpression in lung cancer is associated with recurrent deletions in cis, and we present evidence supporting a tumor-promoting role."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 880,
                    "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 1088,
                    "text": "Recurrent tandem duplications intersecting with a TAD boundary mediate de novo formation of a 3D contact domain comprising IGF2 and a lineage-specific super-enhancer, resulting in high-level gene activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1089,
                    "offsetInEndSection": 1188,
                    "text": "Our framework enables systematic inference of CRE rearrangements mediating dysregulation in cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 204,
                    "text": "Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12748593",
                "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                "http://www.ncbi.nlm.nih.gov/pubmed/10938522",
                "http://www.ncbi.nlm.nih.gov/pubmed/24739076",
                "http://www.ncbi.nlm.nih.gov/pubmed/26885800",
                "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                "http://www.ncbi.nlm.nih.gov/pubmed/7742235",
                "http://www.ncbi.nlm.nih.gov/pubmed/16916049",
                "http://www.ncbi.nlm.nih.gov/pubmed/23439970"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "[Dermatophytosis: a summary of dermatomycosis as a proposal for future revision of the guidelines]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 198,
                    "text": "In preparing guidelines for dermatomycosis (tinea, trichophytia, dermatophytosis), we have primarily summarized the disease types and treatments as described in 4 textbooks used in Japan and abroad."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 273,
                    "text": "We present our classification draft based on these following descriptions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 274,
                    "offsetInEndSection": 443,
                    "text": "In Japan, any dermatophytosis other than favus or tinea imbricata is considered to be tinea, while outside Japan, favus and tinea imbricata are also classified as tinea."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 597,
                    "text": "Tinea capitis is classified together with trichophytia superficialis capillitii and kerion celsi, in a group that tends to include asymptomatic carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 598,
                    "offsetInEndSection": 734,
                    "text": "Most textbooks generally classify trichophytia profunda of the glabrous skin and granuloma trichophyticum as subtypes of tinea corporis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 735,
                    "offsetInEndSection": 868,
                    "text": "Tinea faciei can easily be misdiagnosed, but in many cases can be distinguished from tinea corporis by its specific clinical picture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 869,
                    "offsetInEndSection": 924,
                    "text": "Tinea unguium is regarded as one type of onychomycosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 925,
                    "offsetInEndSection": 1026,
                    "text": "We present a summary of dermatomycosis treatment as a proposal for future revision of the guidelines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1027,
                    "offsetInEndSection": 1195,
                    "text": "One of the problems in the treatment of tinea capitis is that the safety of itraconazole (ITZ) and terbinafine hydrochloride (TBF) in children has not been established."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                "http://www.ncbi.nlm.nih.gov/pubmed/16512914",
                "http://www.ncbi.nlm.nih.gov/pubmed/9326327",
                "http://www.ncbi.nlm.nih.gov/pubmed/2307466",
                "http://www.ncbi.nlm.nih.gov/pubmed/1543902",
                "http://www.ncbi.nlm.nih.gov/pubmed/12297986",
                "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                "http://www.ncbi.nlm.nih.gov/pubmed/9344670"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "The albino-deletion complex of the mouse: molecular mapping of deletion breakpoints that define regions necessary for development of the embryonic and extraembryonic ectoderm."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 313,
                    "text": "Previous complementation analyses with five (c11DSD, c5FR60Hg, c2YPSj, c4FR60Hd, c6H) of the mouse albino deletions defined at least two genes on chromosome 7, known as eed and exed, which are necessary for development of the embryonic and extraembryonic ectoderm, respectively, of early postimplantation embryos."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 314,
                    "offsetInEndSection": 472,
                    "text": "The region of chromosome 7 containing these two genes has now been accessed at the molecular level by cloning two of the deletion breakpoint-fusion fragments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 473,
                    "offsetInEndSection": 614,
                    "text": "The c2YPSj breakpoints were isolated by cloning an EcoRI fragment containing a copy of an albino region-specific repeat unique to c2YPSj DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 615,
                    "offsetInEndSection": 782,
                    "text": "Similarly, the c11DSD breakpoints were isolated by cloning a c11DSD EcoRI fragment detected by a unique-sequence probe mapping proximal to the albino-coat-color locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "abstract",
                    "offsetInBeginSection": 783,
                    "offsetInEndSection": 1099,
                    "text": "By mapping the cloned breakpoints relative to the remaining three deletions, the c11DSD distal breakpoint was found to define the distal limit of the region containing eed, whereas the c2YPSj and c6H distal breakpoints were found to define the proximal and distal limits, respectively, of the region containing exed."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "Murine fumarylacetoacetate hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 426,
                    "text": "Homozygous deletion of the hepatocyte-specific developmental regulation 1 (hsdr-1) locus in mouse chromosome 7 results in perinatal death and a pleiotropic syndrome characterized by ultrastructural abnormalities of the liver and kidney, failure of induction of a number of specific transcription units in the liver and kidney during late gestation, and marked overexpression of an enzyme that defends against oxidative stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 427,
                    "offsetInEndSection": 693,
                    "text": "Previously, the breakpoints of two albino (c) deletions (c14CoS and c1FAFyh) that genetically define hsdr-1 were localized, on a long-range map, in the vicinity of the distal breakpoint of a viable albino deletion (c24R75M) that breaks proximally within the c locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 694,
                    "offsetInEndSection": 879,
                    "text": "Here we report the use of a probe derived from a deletion breakpoint fusion fragment cloned from c24R75M/c24R75M DNA to clone a breakpoint fusion fragment caused by the c14CoS deletion."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                "http://www.ncbi.nlm.nih.gov/pubmed/25630241",
                "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                "http://www.ncbi.nlm.nih.gov/pubmed/22361292",
                "http://www.ncbi.nlm.nih.gov/pubmed/27250657",
                "http://www.ncbi.nlm.nih.gov/pubmed/24920274",
                "http://www.ncbi.nlm.nih.gov/pubmed/25690653",
                "http://www.ncbi.nlm.nih.gov/pubmed/25555588"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "The ubiquitous presence of long noncoding RNAs (lncRNAs) in eukaryotes points to the importance of understanding how their sequences impact function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 428,
                    "offsetInEndSection": 600,
                    "text": "Subcellular localization of BORG was not dependent on the context or level of its expression or decay but rather depended on the sequence of the mature, spliced transcript."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 601,
                    "offsetInEndSection": 863,
                    "text": "Mutational analyses indicated that nuclear localization of BORG was mediated through a novel RNA motif consisting of the pentamer sequence AGCCC with sequence restrictions at positions -8 (T or A) and -3 (G or C) relative to the first nucleotide of the pentamer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 864,
                    "offsetInEndSection": 1092,
                    "text": "Mutation of the motif to a scrambled sequence resulted in complete loss of nuclear localization, while addition of even a single copy of the motif to a cytoplasmically localized RNA was sufficient to impart nuclear localization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1093,
                    "offsetInEndSection": 1300,
                    "text": "Further, the presence of this motif in other cellular RNAs showed a direct correlation with nuclear localization, suggesting that the motif may act as a general nuclear localization signal for cellular RNAs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Some mitochondrial long noncoding RNAs (lncRNAs) are encoded by nuclear DNA, but the mechanisms that mediate their transport to mitochondria are poorly characterized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 440,
                    "text": "Using affinity RNA pull-down followed by mass spectrometry analysis, we found two RNA-binding proteins (RBPs), HuR (human antigen R) and GRSF1 (G-rich RNA sequence-binding factor 1), that associated with the nuclear DNA-encoded lncRNA RMRP and mobilized it to mitochondria."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                "http://www.ncbi.nlm.nih.gov/pubmed/28723572",
                "http://www.ncbi.nlm.nih.gov/pubmed/28075484",
                "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                "http://www.ncbi.nlm.nih.gov/pubmed/27146274",
                "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                "http://www.ncbi.nlm.nih.gov/pubmed/28789639",
                "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                "http://www.ncbi.nlm.nih.gov/pubmed/28138849"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "I-ATAC: interactive pipeline for the management and pre-processing of ATAC-seq samples."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Assay for Transposase Accessible Chromatin (ATAC-seq) is an open chromatin profiling assay that is adapted to interrogate chromatin accessibility from small cell numbers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 269,
                    "text": "ATAC-seq surmounted a major technical barrier and enabled epigenome profiling of clinical samples."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 270,
                    "offsetInEndSection": 395,
                    "text": "With this advancement in technology, we are now accumulating ATAC-seq samples from clinical samples at an unprecedented rate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 396,
                    "offsetInEndSection": 571,
                    "text": "These epigenomic profiles hold the key to uncovering how transcriptional programs are established in diverse human cells and are disrupted by genetic or environmental factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 720,
                    "text": "Thus, the barrier to deriving important clinical insights from clinical epigenomic samples is no longer one of data generation but of data analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 721,
                    "offsetInEndSection": 867,
                    "text": "Specifically, we are still missing easy-to-use software tools that will enable non-computational scientists to analyze their own ATAC-seq samples."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1065,
                    "text": "To facilitate systematic pre-processing and management of ATAC-seq samples, we developed an interactive, cross-platform, user-friendly and customized desktop application: interactive-ATAC (I-ATAC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1066,
                    "offsetInEndSection": 1347,
                    "text": "I-ATAC integrates command-line data processing tools (FASTQC, Trimmomatic, BWA, Picard, ATAC_BAM_shiftrt_gappedAlign.pl, Bedtools and Macs2) into an easy-to-use platform with user interface to automatically pre-process ATAC-seq samples with parallelized and customizable pipelines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1348,
                    "offsetInEndSection": 1565,
                    "text": "Its performance has been tested using public ATAC-seq datasets in GM12878 and CD4+T cells and a feature-based comparison is performed with some available interactive LIMS (Galaxy, SMITH, SeqBench, Wasp, NG6, openBIS)."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                "http://www.ncbi.nlm.nih.gov/pubmed/26854857",
                "http://www.ncbi.nlm.nih.gov/pubmed/23840477",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821439",
                "http://www.ncbi.nlm.nih.gov/pubmed/23869221",
                "http://www.ncbi.nlm.nih.gov/pubmed/24976123",
                "http://www.ncbi.nlm.nih.gov/pubmed/26876161",
                "http://www.ncbi.nlm.nih.gov/pubmed/23316790"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 50,
                    "text": "Designing disorder: Tales of the unexpected tails."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 74,
                    "text": "Protein tags of various sizes and shapes catalyze progress in biosciences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 75,
                    "offsetInEndSection": 125,
                    "text": "Well-folded tags can serve to solubilize proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 262,
                    "text": "Small, unfolded, peptide-like tags have become invaluable tools for protein purification as well as protein-protein interaction studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 263,
                    "offsetInEndSection": 405,
                    "text": "Intrinsically Disordered Proteins (IDPs), which lack unique 3D structures, received exponentially increasing attention during the last decade."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 406,
                    "offsetInEndSection": 559,
                    "text": "Recently, large ID tags have been developed to solubilize proteins and to engineer the pharmacological properties of protein and peptide pharmaceuticals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 560,
                    "offsetInEndSection": 676,
                    "text": "Here, we contrast the complementary benefits and applications of both folded and ID tags based on predictions of ID."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28516025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 735,
                    "text": "Less structure often means more function in a shorter tag."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "The surgical treatment of carbuncles: a tale of two techniques."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "The treatment of carbuncles is early administration of antibiotics and surgery."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                "http://www.ncbi.nlm.nih.gov/pubmed/18469796",
                "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                "http://www.ncbi.nlm.nih.gov/pubmed/9169352",
                "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                "http://www.ncbi.nlm.nih.gov/pubmed/24160789",
                "http://www.ncbi.nlm.nih.gov/pubmed/25862337",
                "http://www.ncbi.nlm.nih.gov/pubmed/24299684",
                "http://www.ncbi.nlm.nih.gov/pubmed/15377360",
                "http://www.ncbi.nlm.nih.gov/pubmed/8009241"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 41,
                    "text": "Mammary and extramammary Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Ten cases of mammary Paget's disease and 10 cases of extramammary Paget's disease were studied for differences of histologic features in them."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 408,
                    "text": "Based on the epidermal changes alone, Paget cells in 90% of specimens from lesions of extramammary Paget's disease had abundant mucin that stained well, whereas Paget cells in only 40% of specimens from mammary Paget's disease stained for mucin and faintly at that."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 442,
                    "text": "In 60% they did not stain at all."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 443,
                    "offsetInEndSection": 620,
                    "text": "The conclusion derived from these observations is that the mucin in Paget cells of extramammary Paget's disease is different from that found in cells of mammary Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "abstract",
                    "offsetInBeginSection": 621,
                    "offsetInEndSection": 860,
                    "text": "The Paget cells in these two conditions seem to have different origins, i.e., those of mammary Paget's disease ascend to the epidermis from lactiferous ducts, whereas those of extramammary Paget's disease originate in the epidermis itself."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8009241",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 51,
                    "text": "Articular complications of Paget's disease of bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8009241",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 54,
                    "text": "Articular symptoms in Paget's disease are very common."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8009241",
                    "endSection": "abstract",
                    "offsetInBeginSection": 55,
                    "offsetInEndSection": 141,
                    "text": "The most frequent cause of articular symptoms is OA, secondary to the Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8009241",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 273,
                    "text": "Radiographic OA due to Paget's disease is not always symptomatic, and periarticular Paget's disease does not invariably lead to OA."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                "http://www.ncbi.nlm.nih.gov/pubmed/3541135",
                "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                "http://www.ncbi.nlm.nih.gov/pubmed/9624479",
                "http://www.ncbi.nlm.nih.gov/pubmed/9158769",
                "http://www.ncbi.nlm.nih.gov/pubmed/11399858",
                "http://www.ncbi.nlm.nih.gov/pubmed/8248237",
                "http://www.ncbi.nlm.nih.gov/pubmed/4985545",
                "http://www.ncbi.nlm.nih.gov/pubmed/12841932"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 38,
                    "text": "Beta-lactamases in anaerobic bacteria."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "The known mechanisms of beta-lactam resistance in anaerobic bacteria involve production of beta-lactamases, alteration of penicillin-binding proteins and blocked penetration of beta-lactams through the outer membranes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 219,
                    "offsetInEndSection": 303,
                    "text": "The most important factor in beta-lactam resistance is production of beta-lactamase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 304,
                    "offsetInEndSection": 402,
                    "text": "Beta-lactamases in various Bacteroides, Fusobacterium and Clostridium species have been described."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 403,
                    "offsetInEndSection": 542,
                    "text": "Beta-lactam resistance in Bacteroides fragilis is most commonly mediated by beta-lactamase production mainly of cephalosporinase character."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 668,
                    "text": "Recent studies have also shown that B. fragilis can produce a penicillinase which inactivates piperacillin and carbenicillin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 669,
                    "offsetInEndSection": 754,
                    "text": "Enzymes inactivating cefoxitin and imipenem have also been isolated from B. fragilis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 755,
                    "offsetInEndSection": 850,
                    "text": "The Bacteroides non-fragilis species produce beta-lactamases of mainly penicillinase character."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 851,
                    "offsetInEndSection": 928,
                    "text": "Recently a penicillinase from Fusobacterium nucleatum has been characterized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 929,
                    "offsetInEndSection": 1051,
                    "text": "Among the clostridia, Clostridium butyricum, C. clostridiiformis and C. ramosum have been shown to produce penicillinases."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                "http://www.ncbi.nlm.nih.gov/pubmed/16772461",
                "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                "http://www.ncbi.nlm.nih.gov/pubmed/21846752",
                "http://www.ncbi.nlm.nih.gov/pubmed/15474307",
                "http://www.ncbi.nlm.nih.gov/pubmed/25162450",
                "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                "http://www.ncbi.nlm.nih.gov/pubmed/28341144",
                "http://www.ncbi.nlm.nih.gov/pubmed/22233209",
                "http://www.ncbi.nlm.nih.gov/pubmed/7777329"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 30,
                    "text": "What's inside your cat's head?"
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "title",
                    "offsetInBeginSection": 31,
                    "offsetInEndSection": 116,
                    "text": "A review of cat (Felis silvestris catus) cognition research past, present and future."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "The domestic cat (Felis silvestris catus) has shared an intertwined existence with humans for thousands of years, living on our city streets and in our homes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 338,
                    "text": "Yet, little scientific research has focused on the cognition of the domestic cat, especially in comparison with human's other companion, the domestic dog (Canis lupus familiaris)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 646,
                    "text": "This review surveys the current status of several areas of cat cognition research including perception, object permanence, memory, physical causality, quantity and time discrimination, cats' sensitivity to human cues, vocal recognition and communication, attachment bonds, personality, and cognitive health."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 647,
                    "offsetInEndSection": 784,
                    "text": "Although interest in cat cognition is growing, we still have a long way to go until we have an inclusive body of research on the subject."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 871,
                    "offsetInEndSection": 1106,
                    "text": "In addition to the scientific value of future work in this area, future research on cat cognition could have an important influence on the management and welfare of pet and free-roaming cats, leading to improved human-cat interactions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Cortisol determination in hair and faeces from domestic cats and dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The present study explored the feasibility of a hair cortisol assay in domestic cats (Felis silvestris catus) and dogs (Canis familiaris) as a valid and reliable alternative to existing non-invasive techniques for monitoring the hypothalamic-pituitary-adrenal (HPA) axis activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                    "endSection": "abstract",
                    "offsetInBeginSection": 281,
                    "offsetInEndSection": 436,
                    "text": "To this aim, 56 new hair growth samples and 870 faecal samples from 27 domestic cats and 29 domestic dogs were collected and cortisol content was assessed."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                "http://www.ncbi.nlm.nih.gov/pubmed/22724006",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                "http://www.ncbi.nlm.nih.gov/pubmed/15941718",
                "http://www.ncbi.nlm.nih.gov/pubmed/9591631",
                "http://www.ncbi.nlm.nih.gov/pubmed/14980504",
                "http://www.ncbi.nlm.nih.gov/pubmed/24725430"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 354,
                    "text": "The 11-zinc finger protein CCTC-binding factor (CTCF) employs different sets of zinc fingers to form distinct complexes with varying CTCF- target sequences (CTSs) that mediate the repression or activation of gene expression and the creation of hormone-responsive gene silencers and of diverse vertebrate enhancer-blocking elements (chromatin insulators)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 355,
                    "offsetInEndSection": 505,
                    "text": "To determine how these varying effects would integrate in vivo, we engineered a variety of expression systems to study effects of CTCF on cell growth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 655,
                    "text": "Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 656,
                    "offsetInEndSection": 831,
                    "text": "In asynchronous cultures, the cell-cycle profile of CTCF-expressing cells remained unaltered, which suggested that progression through the cycle was slowed at multiple points."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 832,
                    "offsetInEndSection": 929,
                    "text": "Although conditionally induced CTCF caused the S-phase block, CTCF can also arrest cell division."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 930,
                    "offsetInEndSection": 1013,
                    "text": "Viable CTCF-expressing cells could be maintained without dividing for several days."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1315,
                    "text": "While MYC is the well-characterized CTCF target, the inhibitory effects of CTCF on cell growth could not be ascribed solely to repression of MYC, suggesting that additional CTS-driven genes involved in growth-regulatory circuits, such as p19ARF, are likely to contribute to CTCF-induced growth arrest."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1316,
                    "offsetInEndSection": 1506,
                    "text": "These findings indicate that CTCF may regulate cell-cycle progression at multiple steps within the cycle, and add to the growing evidence for the function of CTCF as a tumor suppressor gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                "http://www.ncbi.nlm.nih.gov/pubmed/16175160",
                "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                "http://www.ncbi.nlm.nih.gov/pubmed/22988875",
                "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/18855661",
                "http://www.ncbi.nlm.nih.gov/pubmed/18496192",
                "http://www.ncbi.nlm.nih.gov/pubmed/17085780",
                "http://www.ncbi.nlm.nih.gov/pubmed/17622782"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 75,
                    "text": "Kinase activity is required for the toxic effects of mutant LRRK2/dardarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 204,
                    "text": "Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 205,
                    "offsetInEndSection": 311,
                    "text": "However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 392,
                    "text": "In this study, we noted two cellular phenotypes associated with mutant dardarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 393,
                    "offsetInEndSection": 480,
                    "text": "First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 481,
                    "offsetInEndSection": 577,
                    "text": "Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 578,
                    "offsetInEndSection": 723,
                    "text": "Manipulating activity by replacing the kinase domain with a 'kinase-dead' version blocks inclusion body formation and strongly delays cell death."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 857,
                    "text": "This predicts that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1000,
                    "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                "http://www.ncbi.nlm.nih.gov/pubmed/18515656",
                "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768533",
                "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                "http://www.ncbi.nlm.nih.gov/pubmed/12586610",
                "http://www.ncbi.nlm.nih.gov/pubmed/21989989",
                "http://www.ncbi.nlm.nih.gov/pubmed/15523650"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "Transcriptome analysis of the zebrafish model of Diamond-Blackfan anemia from RPS19 deficiency via p53-dependent and -independent pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 162,
                    "text": "Diamond-Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome that is characterized by pure red-cell aplasia and associated physical deformities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 163,
                    "offsetInEndSection": 309,
                    "text": "It has been proven that defects of ribosomal proteins can lead to this disease and that RPS19 is the most frequently mutated gene in DBA patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 310,
                    "offsetInEndSection": 421,
                    "text": "Previous studies suggest that p53-dependent genes and pathways play important roles in RPS19-deficient embryos."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 422,
                    "offsetInEndSection": 512,
                    "text": "However, whether there are other vital factors linked to DBA has not been fully clarified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 513,
                    "offsetInEndSection": 722,
                    "text": "In this study, we compared the whole genome RNA-Seq data of zebrafish embryos injected with RPS19 morpholino (RPS19 MO), RPS19 and p53 morpholino simultaneously (RPS19+p53 MO) and control morpholino (control)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 723,
                    "offsetInEndSection": 941,
                    "text": "We found that genes enriched in the functions of hematological systems, nervous system development and skeletal and muscular disorders had significant differential expression in RPS19 MO embryos compared with controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 942,
                    "offsetInEndSection": 1030,
                    "text": "Co-inhibition of p53 partially alleviates the abnormalities for RPS19-deficient embryos."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1031,
                    "offsetInEndSection": 1184,
                    "text": "However, the hematopoietic genes, which were down-regulated significantly in RPS19 MO embryos, were not completely recovered by the co-inhibition of p53."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1185,
                    "offsetInEndSection": 1278,
                    "text": "Furthermore, we identified the genome-wide p53-dependent and -independent genes and pathways."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151964",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                "http://www.ncbi.nlm.nih.gov/pubmed/2134678",
                "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                "http://www.ncbi.nlm.nih.gov/pubmed/22073317"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Directed evolution and substrate specificity profile of homing endonuclease I-SceI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "The laboratory evolution of enzymes with tailor-made DNA cleavage specificities would represent new tools for manipulating genomes and may enhance our understanding of sequence-specific DNA recognition by nucleases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 484,
                    "text": "Below we describe the development and successful application of an efficient in vivo positive and negative selection system that applies evolutionary pressure either to favor the cleavage of a desired target sequence or to disfavor the cleavage of nontarget sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 485,
                    "offsetInEndSection": 652,
                    "text": "We also applied a previously described in vitro selection method to reveal the comprehensive substrate specificity profile of the wild-type I-SceI homing endonuclease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 782,
                    "text": "Together these tools were used to successfully evolve mutant I-SceI homing endonucleases with altered DNA cleavage specificities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16478204",
                    "endSection": "abstract",
                    "offsetInBeginSection": 783,
                    "offsetInEndSection": 950,
                    "text": "The most highly evolved enzyme cleaves the target mutant DNA sequence with a selectivity that is comparable to wild-type I-SceI's preference for its cognate substrate."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Intragenomic evolution of a transcriptional enhancer in the genome of Strongylocentrotus purpuratus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "General principles for how genomic regulatory elements evolve to alter patterns of gene expression remain vague."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 346,
                    "text": "The purpose of this study was to gain insights into the evolution of genomic regulatory elements by investigating the unique features of a transcriptional enhancer that directs Spec2a gene expression in Strongylocentrotus purpuratus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                    "endSection": "abstract",
                    "offsetInBeginSection": 347,
                    "offsetInEndSection": 446,
                    "text": "The Spec2a enhancer is embedded in a repetitive sequence family interspersed throughout the genome."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27894853",
                "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                "http://www.ncbi.nlm.nih.gov/pubmed/25206437",
                "http://www.ncbi.nlm.nih.gov/pubmed/26589645",
                "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                "http://www.ncbi.nlm.nih.gov/pubmed/26014322",
                "http://www.ncbi.nlm.nih.gov/pubmed/28718333",
                "http://www.ncbi.nlm.nih.gov/pubmed/23590784",
                "http://www.ncbi.nlm.nih.gov/pubmed/28447963"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 55,
                    "text": "Carpal tunnel syndrome following automobile collisions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Seven patients developed symptoms and signs of carpal tunnel syndrome after vehicles they were driving were involved in collisions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 132,
                    "offsetInEndSection": 251,
                    "text": "Nerve conduction studies showed median nerve impairment at the wrist in 4 patients and suggested it in the other three."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 252,
                    "offsetInEndSection": 405,
                    "text": "The presence of carpal tunnel syndrome was confirmed in every patient by the relief of symptoms following surgical division of the volar carpal ligament."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 406,
                    "offsetInEndSection": 610,
                    "text": "The findings suggest that injuries inflicted on nonneural structures of the carpal tunnel when the patient was gripping the steering wheel led to chronic compression of the median nerve within the tunnel."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 42,
                    "text": "Pathophysiology of carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 217,
                    "text": "Carpal tunnel syndrome presents in 3.8% of the general population, with a higher prevalence among women."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 218,
                    "offsetInEndSection": 317,
                    "text": "There are several risk factors associated with CTS, including both medical and non medical factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 318,
                    "offsetInEndSection": 467,
                    "text": "The pathophysiologic mechanisms involved in the median nerve compression and traction are thought to be complex, and as yet are not fully understood."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                "http://www.ncbi.nlm.nih.gov/pubmed/18803461",
                "http://www.ncbi.nlm.nih.gov/pubmed/24348049",
                "http://www.ncbi.nlm.nih.gov/pubmed/28273952",
                "http://www.ncbi.nlm.nih.gov/pubmed/19592613",
                "http://www.ncbi.nlm.nih.gov/pubmed/23970168",
                "http://www.ncbi.nlm.nih.gov/pubmed/28428687",
                "http://www.ncbi.nlm.nih.gov/pubmed/25349139"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "The extracellular matrix (ECM) plays a critical role during the development and invasion of primary brain tumours."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 243,
                    "text": "However, the function of ECM components and signalling between a permissive ECM and invasive astrocytes is not fully understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 244,
                    "offsetInEndSection": 403,
                    "text": "We have recently reported the ECM enzyme, lysyl oxidase (LOX), in the central nervous system and observed up-regulation of LOX in anaplastic astrocytoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 404,
                    "offsetInEndSection": 645,
                    "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 646,
                    "offsetInEndSection": 801,
                    "text": "In this study, we tested the hypothesis that active LOX is expressed in anaplastic astrocytes and promotes FAK activation and invasive/migratory behaviour."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 802,
                    "offsetInEndSection": 950,
                    "text": "Results demonstrate that increased expression and activity of LOX positively correlated with invasive phenotype of malignant astrocytoma cell lines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 951,
                    "offsetInEndSection": 1190,
                    "text": "Immunohistochemistry detected increased LOX within tumour cells and ECM in grade I-IV astrocytic neoplasm compared with normal brain and coincidence of increased LOX with the loss of glial fibrillary acidic protein in higher-grade tumours."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1191,
                    "offsetInEndSection": 1486,
                    "text": "Increased active LOX in invasive astrocytes was accompanied by phosphorylation of FAK[Tyr576] and paxillin[Tyr118]; furthermore, both FAK and paxillin tyrosine phosphorylation were diminished by beta-aminopropionitrile inhibition of LOX activity and depletion of H(2)O(2) via catalase treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1487,
                    "offsetInEndSection": 1688,
                    "text": "Additionally, we provide evidence that in astrocytes, LOX is likely processed by bone morphogenic protein-1 and LOX activity might be further stimulated by the expression of fibronectin in these cells."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                "http://www.ncbi.nlm.nih.gov/pubmed/24736271",
                "http://www.ncbi.nlm.nih.gov/pubmed/15043175",
                "http://www.ncbi.nlm.nih.gov/pubmed/19841603",
                "http://www.ncbi.nlm.nih.gov/pubmed/21094795",
                "http://www.ncbi.nlm.nih.gov/pubmed/23769085",
                "http://www.ncbi.nlm.nih.gov/pubmed/2587453",
                "http://www.ncbi.nlm.nih.gov/pubmed/10646765",
                "http://www.ncbi.nlm.nih.gov/pubmed/9589847",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404597"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the D\u00fcsseldorf DCB registry."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "BACKGROUND\nIn-stent restenosis (ISR) is still a major concern in interventional cardiology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 92,
                    "offsetInEndSection": 190,
                    "text": "Drug coated balloon (DCB) angioplasty has been shown to be a promising option in treatment of ISR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 191,
                    "offsetInEndSection": 321,
                    "text": "However heterogeneity of different DCBs in suppression of neointimal growth has been described in a porcine model of coronary ISR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 322,
                    "offsetInEndSection": 460,
                    "text": "Therefore, in this registry analysis, we compared two frequently used paclitaxel eluting DCBs, the SeQuent Please and the Pantera Lux DCB."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 463,
                    "offsetInEndSection": 584,
                    "text": "METHODS\n571 patients were treated with DCB angioplasty at the Heinrich-Heine University D\u00fcsseldorf between 2009 and 2012."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 585,
                    "offsetInEndSection": 650,
                    "text": "Follow-up was conducted during ambulatory care at our department."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 651,
                    "offsetInEndSection": 805,
                    "text": "Major adverse cardiac events (death, myocardial infarction [MI] and target lesion revascularization) were registered during hospitalization and follow-up."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 808,
                    "offsetInEndSection": 1009,
                    "text": "RESULTS\nPatient characteristics, prior diseases, clinical presentation, ejection fraction, procedural success and lost-for-follow-up did not differ between patients treated with the SeQuent Please and."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1010,
                    "offsetInEndSection": 1030,
                    "text": "The Pantera Lux DCB."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                "http://www.ncbi.nlm.nih.gov/pubmed/9566734",
                "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                "http://www.ncbi.nlm.nih.gov/pubmed/3138978",
                "http://www.ncbi.nlm.nih.gov/pubmed/8422755",
                "http://www.ncbi.nlm.nih.gov/pubmed/20440461"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "The relationship between oral contraceptive use and sensitivity to olfactory stimuli."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 236,
                    "text": "The present study examined differences in olfactory sensitivity between 16 naturally cycling (NC) women and 17 women taking monophasic oral contraceptives (OCs) to six odors: lemon, peppermint, rose, musk, androstenone and androsterone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 237,
                    "offsetInEndSection": 394,
                    "text": "Thresholds were assessed twice for both groups of women (during the periovulatory and luteal phases of their cycles) via a forced-choice discrimination task."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 395,
                    "offsetInEndSection": 527,
                    "text": "NC women in the periovulatory phase were significantly more sensitive to androstenone, androsterone, and musk than women taking OCs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 528,
                    "offsetInEndSection": 606,
                    "text": "These findings give support to odor-specific hormonal modulation of olfaction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 607,
                    "offsetInEndSection": 841,
                    "text": "Further, due to the social and possibly sexual nature of these odors, future work should address whether there is a relationship between decreased sensitivity to these odors and reported behavioral side effects among women taking OCs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "Olfactory sensitivity to two odorants, isoamyl acetate and androsterone, was assessed in 14 obsessive compulsive disorder (OCD) patients, nine major depressive disorder (MDD) patients, and 16 sex- and age-matched healthy controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 345,
                    "text": "Tests were performed during a drug-free period, and 3 and 6 weeks after initiation of antidepressant drug therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 461,
                    "text": "No difference in olfactory sensitivity, to either odorant, was found between OCD patients and controls at any time."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                "http://www.ncbi.nlm.nih.gov/pubmed/2735530",
                "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                "http://www.ncbi.nlm.nih.gov/pubmed/9622323",
                "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                "http://www.ncbi.nlm.nih.gov/pubmed/24705744",
                "http://www.ncbi.nlm.nih.gov/pubmed/6667428",
                "http://www.ncbi.nlm.nih.gov/pubmed/24788547",
                "http://www.ncbi.nlm.nih.gov/pubmed/27061802"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Fractures of the body of the tarsal navicular bone: case reports and literature review."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Four patients sustaining tarsal navicular body fractures are presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 72,
                    "offsetInEndSection": 356,
                    "text": "Analysis based on these cases and on 36 patients suffering from identical fractures reported in the literature led to a new mechanical assumption: the axial compression on the foot, as a result of falling from height, causes impaction of the talus into the body of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 357,
                    "offsetInEndSection": 422,
                    "text": "The clinical followup results reported are usually disappointing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 568,
                    "text": "Favorable results are obtained in a vertical two-part fracture, by an open reduction and internal fixation of the tarsal navicular body fracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 569,
                    "offsetInEndSection": 657,
                    "text": "In highly comminuted fractures, talo-navicular-cuneiform arthrodesis can be carried out."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Osteomyelitis of the accessory and body of the navicular bone: a case report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "A 16-year-old boy developed left foot pain of unknown cause that was unresponsive to conservative treatment, associated with fever and difficulty walking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 254,
                    "text": "He was admitted to our hospital with osteomyelitis of the accessory and body of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 255,
                    "offsetInEndSection": 355,
                    "text": "Surgery could not be performed because the patient had been diagnosed with Wiskott-Aldrich syndrome."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                "http://www.ncbi.nlm.nih.gov/pubmed/26676325",
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                "http://www.ncbi.nlm.nih.gov/pubmed/20392463",
                "http://www.ncbi.nlm.nih.gov/pubmed/20478902"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Myocardial Infarction-Associated Transcript, a Long Noncoding RNA, Is Overexpressed During Dilated Cardiomyopathy Due to Chronic Chagas Disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "Long noncoding RNAs (lncRNAs) modulate gene expression at the epigenetic, transcriptional, and posttranscriptional levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 258,
                    "text": "Dysregulation of the lncRNA known as myocardial infarction-associated transcript (MIAT) has been associated with myocardial infarction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 340,
                    "text": "Chagas disease causes a severe inflammatory dilated chronic cardiomyopathy (CCC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 341,
                    "offsetInEndSection": 381,
                    "text": "We investigated the role of MIAT in CCC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 624,
                    "text": "A whole-transcriptome analysis of heart biopsy specimens and formalin-fixed, paraffin-embedded samples revealed that MIAT was overexpressed in patients with CCC, compared with subjects with noninflammatory dilated cardiomyopathy and controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 625,
                    "offsetInEndSection": 671,
                    "text": "These results were confirmed in a mouse model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 672,
                    "offsetInEndSection": 729,
                    "text": "Results suggest that MIAT is a specific biomarker of CCC."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26676325",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Differential lncRNA\u2011mRNA co\u2011expression network analysis revealing the potential regulatory roles of lncRNAs in myocardial infarction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26676325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Previous studies have reported that long, non\u2011coding RNAs (lncRNAs) are important in cardiovascular disease."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                "http://www.ncbi.nlm.nih.gov/pubmed/2363420",
                "http://www.ncbi.nlm.nih.gov/pubmed/18484624",
                "http://www.ncbi.nlm.nih.gov/pubmed/19482440",
                "http://www.ncbi.nlm.nih.gov/pubmed/21552526",
                "http://www.ncbi.nlm.nih.gov/pubmed/12597376",
                "http://www.ncbi.nlm.nih.gov/pubmed/19571053",
                "http://www.ncbi.nlm.nih.gov/pubmed/23146638"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 183,
                    "text": "The heterogeneous group of disorders known as oculocutaneous albinism (OCA) shares cutaneous and ocular hypopigmentation associated with common developmental abnormalities of the eye."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 184,
                    "offsetInEndSection": 237,
                    "text": "Mutations of at least 11 loci produce this phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 238,
                    "offsetInEndSection": 386,
                    "text": "The majority of affected individuals develop some cutaneous melanin; this is predominantly seen as yellow/blond hair, whereas fewer have brown hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 627,
                    "text": "The OCA phenotype is dependent on the constitutional pigmentation background of the family, with more OCA pigmentation found in families with darker constitutional pigmentation, which indicates that other genes may modify the OCA phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 775,
                    "text": "Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 840,
                    "text": "We identified eight probands with OCA who had red hair at birth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 841,
                    "offsetInEndSection": 1114,
                    "text": "Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1115,
                    "offsetInEndSection": 1195,
                    "text": "This is the first demonstration of a gene modifying the OCA phenotype in humans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/10573394",
                "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                "http://www.ncbi.nlm.nih.gov/pubmed/2695392",
                "http://www.ncbi.nlm.nih.gov/pubmed/403933",
                "http://www.ncbi.nlm.nih.gov/pubmed/8760442",
                "http://www.ncbi.nlm.nih.gov/pubmed/6263856",
                "http://www.ncbi.nlm.nih.gov/pubmed/344144",
                "http://www.ncbi.nlm.nih.gov/pubmed/3025707",
                "http://www.ncbi.nlm.nih.gov/pubmed/9653552"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Phenotypically cryptic EcoRI endonuclease activity specified by the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 379,
                    "text": "Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 380,
                    "offsetInEndSection": 452,
                    "text": "No EcoRI DNA methylase activity associated with ColE1 has been detected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 453,
                    "offsetInEndSection": 734,
                    "text": "The finding of phenotypically cryptic ColE1-dependent EcoRI endonuclease activity and the absence of any detectable EcoRI modification system in ColE1-containing cells suggest a control mechanism that appears to prevent functional expression of the ColE1-determined enzyme in vivo."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "[Characteristics of RecA-independent recombination of plasmids in E. coli cells producing restriction endonuclease EcoRI]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "The restriction endonuclease EcoRI dependent recombination of compatible plasmids has been studied in RecA cells of Escherichia coli."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 304,
                    "text": "Plasmid RP4 and the isogenic ColE1 type plasmids pSA14 or pSA25, differing in restriction-modification RM EcoRI genes, have been used to study this type of recombination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 449,
                    "text": "EcoRI dependent recombination of plasmids is demonstrated in RecA cells and, thus, is independent of general system of homologous recombination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 565,
                    "text": "The classes of recombinant plasmids isolated from RecA cells differ from the classes isolated from wild type cells."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                "http://www.ncbi.nlm.nih.gov/pubmed/19127040",
                "http://www.ncbi.nlm.nih.gov/pubmed/14716388",
                "http://www.ncbi.nlm.nih.gov/pubmed/21982529",
                "http://www.ncbi.nlm.nih.gov/pubmed/16011530",
                "http://www.ncbi.nlm.nih.gov/pubmed/28483415",
                "http://www.ncbi.nlm.nih.gov/pubmed/19245939",
                "http://www.ncbi.nlm.nih.gov/pubmed/15525297",
                "http://www.ncbi.nlm.nih.gov/pubmed/11428412"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 67,
                    "text": "Cryptococcal meningitis in Rio de Janeiro State, Brazil, 1994-2004."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The objective of this article was to evaluate the epidemiology of cryptococcal meningitis in Rio de Janeiro State, Brazil, from 1994 to 2004."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 271,
                    "text": "Six hundred and ninety-six cases of cryptococcal meningitis were reported, with a mean incidence of 0.45 per 100,000 inhabitants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 272,
                    "offsetInEndSection": 433,
                    "text": "Patients were predominantly male; mean age was 35.9 years; AIDS was practically the only underlying disease, reported in 61.2% of cases; case-fatality was 51.8%."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 495,
                    "text": "No decline in incidence was observed during the study period."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 496,
                    "offsetInEndSection": 633,
                    "text": "AIDS is the main predisposing condition for cryptococcal meningitis, and thus the profile of most patients mirrors that of HIV infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 634,
                    "offsetInEndSection": 708,
                    "text": "Missing information prevented the evaluation of other underlying diseases."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14716388",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 26,
                    "text": "[Cryptococcal meningitis]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14716388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "BACKGROUND\nCryptococcus neoformans causes systemic disease in patients with immunodeficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14716388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 94,
                    "offsetInEndSection": 188,
                    "text": "The incidence of cryptococcal meningitis has increased in parallel with that of HIV infection."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                "http://www.ncbi.nlm.nih.gov/pubmed/20961960",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                "http://www.ncbi.nlm.nih.gov/pubmed/24513612",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                "http://www.ncbi.nlm.nih.gov/pubmed/26781569",
                "http://www.ncbi.nlm.nih.gov/pubmed/26294746"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "High-altitude hypoxia (reduced inspired oxygen tension due to decreased barometric pressure) exerts severe physiological stress on the human body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 260,
                    "text": "Two high-altitude regions where humans have lived for millennia are the Andean Altiplano and the Tibetan Plateau."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 261,
                    "offsetInEndSection": 393,
                    "text": "Populations living in these regions exhibit unique circulatory, respiratory, and hematological adaptations to life at high altitude."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 394,
                    "offsetInEndSection": 512,
                    "text": "Although these responses have been well characterized physiologically, their underlying genetic basis remains unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 513,
                    "offsetInEndSection": 600,
                    "text": "We performed a genome scan to identify genes showing evidence of adaptation to hypoxia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 601,
                    "offsetInEndSection": 731,
                    "text": "We looked across each chromosome to identify genomic regions with previously unknown function with respect to altitude phenotypes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 732,
                    "offsetInEndSection": 921,
                    "text": "In addition, groups of genes functioning in oxygen metabolism and sensing were examined to test the hypothesis that particular pathways have been involved in genetic adaptation to altitude."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1153,
                    "text": "Applying four population genetic statistics commonly used for detecting signatures of natural selection, we identified selection-nominated candidate genes and gene regions in these two populations (Andeans and Tibetans) separately."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1154,
                    "offsetInEndSection": 1351,
                    "text": "The Tibetan and Andean patterns of genetic adaptation are largely distinct from one another, with both populations showing evidence of positive natural selection in different genes or gene regions."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                "http://www.ncbi.nlm.nih.gov/pubmed/27498420",
                "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                "http://www.ncbi.nlm.nih.gov/pubmed/29224101",
                "http://www.ncbi.nlm.nih.gov/pubmed/22535970",
                "http://www.ncbi.nlm.nih.gov/pubmed/25390014",
                "http://www.ncbi.nlm.nih.gov/pubmed/23603815",
                "http://www.ncbi.nlm.nih.gov/pubmed/27339605",
                "http://www.ncbi.nlm.nih.gov/pubmed/19906816"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Brown adipose tissue (BAT) is specialized for energy expenditure, a process called adaptive thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 239,
                    "text": "PET-CT scans recently demonstrated the existence of metabolically active BAT in adult humans, which revitalized our interest in BAT."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 367,
                    "text": "Increasing the amount and/or activity of BAT holds tremendous promise for the treatment of obesity and its associated diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 368,
                    "offsetInEndSection": 436,
                    "text": "PGC1\u03b1 is the master regulator of UCP1-mediated thermogenesis in BAT."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 437,
                    "offsetInEndSection": 609,
                    "text": "A number of proteins have been identified to influence thermogenesis either positively or negatively through regulating the expression or transcriptional activity of PGC1\u03b1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 610,
                    "offsetInEndSection": 776,
                    "text": "Therefore, BAT activation can be achieved by either inducing the expression of positive regulators of PGC1\u03b1 or by inhibiting the repressors of the PGC1\u03b1/UCP1 pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 777,
                    "offsetInEndSection": 916,
                    "text": "Here, we review the most important negative regulators of PGC1\u03b1/UCP1 signaling and their mechanism of action in BAT-mediated thermogenesis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 190,
                    "text": "Fibroblast growth factor-21 (FGF21) is a pleiotropic protein involved in glucose, lipid metabolism and energy homeostasis, with main tissues of expression being the liver and adipose tissue."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/26204497",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 183,
                    "text": "BACKGROUND\nCurrent methods widely deployed for colorectal cancers (CRC) screening lack the necessary sensitivity and specificity required for population-based early disease detection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 184,
                    "offsetInEndSection": 354,
                    "text": "Cancer-specific protein biomarkers are thought to be produced either by the tumor itself or other tissues in response to the presence of cancers or associated conditions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 355,
                    "offsetInEndSection": 516,
                    "text": "Equally, known examples of cancer protein biomarkers (e.g., PSA, CA125, CA19-9, CEA, AFP) are frequently found in plasma at very low concentration (pg/mL-ng/mL)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 675,
                    "text": "New sensitive and specific assays are therefore urgently required to detect the disease at an early stage when prognosis is good following surgical resection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 676,
                    "offsetInEndSection": 880,
                    "text": "This study was designed to meet the longstanding unmet clinical need for earlier CRC detection by measuring plasma candidate biomarkers of cancer onset and progression in a clinical stage-specific manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 1165,
                    "text": "EDTA plasma samples (1\u00a0\u03bcL) obtained from 75 patients with Dukes' staged CRC or unaffected controls (age and sex matched with stringent inclusion/exclusion criteria) were assayed for expression of 92 human proteins employing the Proseek\u00ae Multiplex Oncology I proximity extension assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1166,
                    "offsetInEndSection": 1278,
                    "text": "An identical set of plasma samples were analyzed utilizing the Bio-Plex Pro\u2122 human cytokine 27-plex immunoassay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                "http://www.ncbi.nlm.nih.gov/pubmed/25606465",
                "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                "http://www.ncbi.nlm.nih.gov/pubmed/17920180",
                "http://www.ncbi.nlm.nih.gov/pubmed/20810002",
                "http://www.ncbi.nlm.nih.gov/pubmed/16360899"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 78,
                    "text": "A regulatory monoamine oxidase a promoter polymorphism and personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Monoamine oxidase type A (MAOA) has been implicated to be part of mechanisms underlying human temperament and psychiatric disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 274,
                    "text": "We hypothesised that a functional polymorphism in the 5' untranslated region of the MAOA gene is associated with specific personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 275,
                    "offsetInEndSection": 567,
                    "text": "In 371 healthy Caucasians, we estimated personality traits by the use of the Karolinska Scales of Personality (KSP), Scandinavian Universities Scales of Personality, Health-Relevant 5-Factor Personality inventory, Temperament and Character Inventory and the revised NEO Personality Inventory."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 568,
                    "offsetInEndSection": 753,
                    "text": "In the same subjects, we analysed the genotype of a polymorphic region consisting of a variable number of a 30-bp repeat sequence located approximately 1.2 kb upstream of the MAOA gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 754,
                    "offsetInEndSection": 926,
                    "text": "After correction for multiple testing, no statistically significant differences between MAOA genotype and personality were observed in men (n = 206) nor in women (n = 165)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 927,
                    "offsetInEndSection": 1099,
                    "text": "We conclude that the structure of this MAOA promoter region does not have a large impact on the expression of personality characteristics in the present Swedish population."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 223,
                    "offsetInEndSection": 463,
                    "text": "This study aimed to investigate associations between MAOA and MAOB polymorphisms and personality traits of positive and negative emotionality in healthy volunteers, to elucidate mechanisms underlying personality and the risk for depression."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27345839",
                "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                "http://www.ncbi.nlm.nih.gov/pubmed/10220385",
                "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                "http://www.ncbi.nlm.nih.gov/pubmed/26232305",
                "http://www.ncbi.nlm.nih.gov/pubmed/20072728",
                "http://www.ncbi.nlm.nih.gov/pubmed/22621256",
                "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                "http://www.ncbi.nlm.nih.gov/pubmed/26645980"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 39,
                    "text": "HDAC inhibitors and chaperone function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "Cellular chaperones promote the folding and maturation of newly synthesized proteins and partially folded proteins in the cytosol and endoplasmic reticulum (ER) as well as prevent the aggregation of misfolded proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 219,
                    "offsetInEndSection": 435,
                    "text": "Histone deacetylases (HDACs) and histone acetyl transferases catalyze the reversible acetylation of histones and nonhistone substrates to control the epigenetic and transcriptomic landscape of normal and tumor cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 667,
                    "text": "Treatment with HDAC inhibitors results in the hyperacetylation of chaperones including heat shock protein (hsp)90, hsp70, hsp40, and the ER-resident hsp70 homolog, glucose-regulated protein 78 (GRP78), which affects their function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 668,
                    "offsetInEndSection": 823,
                    "text": "HDAC inhibitor-mediated deregulation of chaperone function, in turn, deregulates protein homeostasis and induces protein misfolding and proteotoxic stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 824,
                    "offsetInEndSection": 1016,
                    "text": "In the context of tumors which are particularly dependent on functional chaperones for maintaining protein homeostasis, HDAC inhibitors tip the balance toward lethal proteotoxic and ER stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1017,
                    "offsetInEndSection": 1206,
                    "text": "In this chapter, we describe HDAC inhibitor-induced hyperacetylation of major chaperones and its implication for the use of HDAC inhibitors in the treatment of solid and hematologic tumors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Activity-based probes for proteomic profiling of histone deacetylase complexes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Histone deacetylases (HDACs) are key regulators of gene expression that require assembly into larger protein complexes for activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 303,
                    "text": "Efforts to understand how associated proteins modulate the function of HDACs would benefit from new technologies that evaluate HDAC activity in native biological systems."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                "http://www.ncbi.nlm.nih.gov/pubmed/26275423",
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/8054978",
                "http://www.ncbi.nlm.nih.gov/pubmed/17033956",
                "http://www.ncbi.nlm.nih.gov/pubmed/8502555",
                "http://www.ncbi.nlm.nih.gov/pubmed/7816810",
                "http://www.ncbi.nlm.nih.gov/pubmed/24698368",
                "http://www.ncbi.nlm.nih.gov/pubmed/27887571"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "The budding yeast Centromere DNA Element II wraps a stable Cse4 hemisome in either orientation in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 169,
                    "text": "In budding yeast, a single cenH3 (Cse4) nucleosome occupies the \u223c120-bp functional centromere, however conflicting structural models for the particle have been proposed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 332,
                    "text": "To resolve this controversy, we have applied H4S47C-anchored cleavage mapping, which reveals the precise position of histone H4 in every nucleosome in the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 516,
                    "text": "We find that cleavage patterns at centromeres are unique within the genome and are incompatible with symmetrical structures, including octameric nucleosomes and (Cse4/H4)2 tetrasomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 759,
                    "text": "Centromere cleavage patterns are compatible with a precisely positioned core structure, one in which each of the 16 yeast centromeres is occupied by oppositely oriented Cse4/H4/H2A/H2B hemisomes in two rotational phases within the population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 760,
                    "offsetInEndSection": 907,
                    "text": "Centromere-specific hemisomes are also inferred from distances observed between closely-spaced H4 cleavages, as predicted from structural modeling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 908,
                    "offsetInEndSection": 1077,
                    "text": "Our results indicate that the orientation and rotational position of the stable hemisome at each yeast centromere is not specified by the functional centromere sequence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1078,
                    "offsetInEndSection": 1125,
                    "text": "DOI: http://dx.doi.org/10.7554/eLife.01861.001."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 67,
                    "text": "Asymmetric nucleosomes flank promoters in the budding yeast genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Nucleosomes in active chromatin are dynamic, but whether they have distinct structural conformations is unknown."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                "http://www.ncbi.nlm.nih.gov/pubmed/27264557",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                "http://www.ncbi.nlm.nih.gov/pubmed/22135286",
                "http://www.ncbi.nlm.nih.gov/pubmed/28570559",
                "http://www.ncbi.nlm.nih.gov/pubmed/25775267",
                "http://www.ncbi.nlm.nih.gov/pubmed/29243925",
                "http://www.ncbi.nlm.nih.gov/pubmed/24989122",
                "http://www.ncbi.nlm.nih.gov/pubmed/25643323"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Expression and Structural Analyses of Human DNA Polymerase \u03b8 (POLQ)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 245,
                    "text": "Pol \u03b8 is the defining enzyme for a pathway of DSB repair termed \"alternative end-joining\" (altEJ) or \"theta-mediated end-joining.\""
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 246,
                    "offsetInEndSection": 332,
                    "text": "This pathway contributes significantly to the radiation resistance of mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 551,
                    "text": "It also modulates accuracy in repair of breaks that occur at stalled DNA replication forks, during diversification steps of the mammalian immune system, during repair of CRISPR-Cas9, and in many DNA integration events."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 670,
                    "text": "Pol \u03b8 is a potentially important clinical target, particularly for cancers deficient in other break repair strategies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 671,
                    "offsetInEndSection": 745,
                    "text": "The enzyme is uniquely able to mediate joining of single-stranded 3' ends."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 746,
                    "offsetInEndSection": 884,
                    "text": "Because of these unusual biochemical properties and its therapeutic importance, it is essential to study structures of pol \u03b8 bound to DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 1152,
                    "text": "However, challenges for expression and purification are presented by the large size of pol \u03b8 (2590 residues in humans) and unusual juxtaposition of domains (a helicase-like domain and distinct DNA polymerase, separated by a region predicted to be largely disordered)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1153,
                    "offsetInEndSection": 1342,
                    "text": "Here we summarize work on the expression and purification of the full-length protein, and then focus on the design, expression, and purification of an active C-terminal polymerase fragment."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                "http://www.ncbi.nlm.nih.gov/pubmed/19277018",
                "http://www.ncbi.nlm.nih.gov/pubmed/20170628",
                "http://www.ncbi.nlm.nih.gov/pubmed/20924363",
                "http://www.ncbi.nlm.nih.gov/pubmed/8213828",
                "http://www.ncbi.nlm.nih.gov/pubmed/19844193",
                "http://www.ncbi.nlm.nih.gov/pubmed/19796077",
                "http://www.ncbi.nlm.nih.gov/pubmed/18806224"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Duchenne muscular dystrophy (DMD) is a lethal genetic disorder caused by an absence of the dystrophin protein in bodywide muscles, including the heart."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 152,
                    "offsetInEndSection": 202,
                    "text": "Cardiomyopathy is a leading cause of death in DMD."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 203,
                    "offsetInEndSection": 395,
                    "text": "Exon skipping via synthetic phosphorodiamidate morpholino oligomers (PMOs) represents one of the most promising therapeutic options, yet PMOs have shown very little efficacy in cardiac muscle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 396,
                    "offsetInEndSection": 627,
                    "text": "To increase therapeutic potency in cardiac muscle, we tested a next-generation morpholino: arginine-rich, cell-penetrating peptide-conjugated PMOs (PPMOs) in the canine X-linked muscular dystrophy in Japan (CXMDJ) dog model of DMD."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 766,
                    "text": "A PPMO cocktail designed to skip dystrophin exons 6 and 8 was injected intramuscularly, intracoronarily, or intravenously into CXMDJ dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 907,
                    "text": "Intravenous injections with PPMOs restored dystrophin expression in the myocardium and cardiac Purkinje fibers, as well as skeletal muscles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 908,
                    "offsetInEndSection": 1019,
                    "text": "Vacuole degeneration of cardiac Purkinje fibers, as seen in DMD patients, was ameliorated in PPMO-treated dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1020,
                    "offsetInEndSection": 1099,
                    "text": "Although symptoms and functions in skeletal muscle were not ameliorated by i.v."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1100,
                    "offsetInEndSection": 1236,
                    "text": "treatment, electrocardiogram abnormalities (increased Q-amplitude and Q/R ratio) were improved in CXMDJ dogs after intracoronary or i.v."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/27929395",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27614453",
                "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                "http://www.ncbi.nlm.nih.gov/pubmed/27796758",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                "http://www.ncbi.nlm.nih.gov/pubmed/28253710"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 59,
                    "text": "Natural RNA circles function as efficient microRNA sponges."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression that act by direct base pairing to target sites within untranslated regions of messenger RNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 179,
                    "offsetInEndSection": 357,
                    "text": "Recently, miRNA activity has been shown to be affected by the presence of miRNA sponge transcripts, the so-called competing endogenous RNA in humans and target mimicry in plants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 358,
                    "offsetInEndSection": 450,
                    "text": "We previously identified a highly expressed circular RNA (circRNA) in human and mouse brain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 578,
                    "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 579,
                    "offsetInEndSection": 747,
                    "text": "ciRS-7 contains more than 70 selectively conserved miRNA target sites, and it is highly and widely associated with Argonaute (AGO) proteins in a miR-7-dependent manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 921,
                    "text": "Although the circRNA is completely resistant to miRNA-mediated target destabilization, it strongly suppresses miR-7 activity, resulting in increased levels of miR-7 targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 922,
                    "offsetInEndSection": 1104,
                    "text": "In the mouse brain, we observe overlapping co-expression of ciRS-7 and miR-7, particularly in neocortical and hippocampal neurons, suggesting a high degree of endogenous interaction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1105,
                    "offsetInEndSection": 1307,
                    "text": "We further show that the testis-specific circRNA, sex-determining region Y (Sry), serves as a miR-138 sponge, suggesting that miRNA sponge effects achieved by circRNA formation are a general phenomenon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1308,
                    "offsetInEndSection": 1411,
                    "text": "This study serves as the first, to our knowledge, functional analysis of a naturally expressed circRNA."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                "http://www.ncbi.nlm.nih.gov/pubmed/24324923",
                "http://www.ncbi.nlm.nih.gov/pubmed/26061054",
                "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                "http://www.ncbi.nlm.nih.gov/pubmed/23690942",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                "http://www.ncbi.nlm.nih.gov/pubmed/23033984",
                "http://www.ncbi.nlm.nih.gov/pubmed/28678867"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The adult human distal gut microbial community is typically dominated by 2 bacterial phyla (divisions), the Firmicutes and the Bacteroidetes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 227,
                    "text": "Little is known about the factors that govern the interactions between their members."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 228,
                    "offsetInEndSection": 297,
                    "text": "Here, we examine the niches of representatives of both phyla in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 466,
                    "text": "Finished genome sequences were generated from Eubacterium rectale and E. eligens, which belong to Clostridium Cluster XIVa, one of the most common gut Firmicute clades."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 467,
                    "offsetInEndSection": 655,
                    "text": "Comparison of these and 25 other gut Firmicutes and Bacteroidetes indicated that the Firmicutes possess smaller genomes and a disproportionately smaller number of glycan-degrading enzymes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 656,
                    "offsetInEndSection": 947,
                    "text": "Germ-free mice were then colonized with E. rectale and/or a prominent human gut Bacteroidetes, Bacteroides thetaiotaomicron, followed by whole-genome transcriptional profiling, high-resolution proteomic analysis, and biochemical assays of microbial-microbial and microbial-host interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 948,
                    "offsetInEndSection": 1198,
                    "text": "B. thetaiotaomicron adapts to E. rectale by up-regulating expression of a variety of polysaccharide utilization loci encoding numerous glycoside hydrolases, and by signaling the host to produce mucosal glycans that it, but not E. rectale, can access."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1199,
                    "offsetInEndSection": 1516,
                    "text": "E. rectale adapts to B. thetaiotaomicron by decreasing production of its glycan-degrading enzymes, increasing expression of selected amino acid and sugar transporters, and facilitating glycolysis by reducing levels of NADH, in part via generation of butyrate from acetate, which in turn is used by the gut epithelium."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1517,
                    "offsetInEndSection": 1764,
                    "text": "This simplified model of the human gut microbiota illustrates niche specialization and functional redundancy within members of its major bacterial phyla, and the importance of host glycans as a nutrient foundation that ensures ecosystem stability."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                "http://www.ncbi.nlm.nih.gov/pubmed/19868347",
                "http://www.ncbi.nlm.nih.gov/pubmed/27087559",
                "http://www.ncbi.nlm.nih.gov/pubmed/23873723",
                "http://www.ncbi.nlm.nih.gov/pubmed/18261201",
                "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                "http://www.ncbi.nlm.nih.gov/pubmed/20300380",
                "http://www.ncbi.nlm.nih.gov/pubmed/8599063"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Epidemiological, Clinical and Entomological Characteristics of Yellow Fever Outbreak in Darfur 2012."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "The study aims at analyzing the epidemiological, clinical and entomological characteristics of Darfur yellow fever epidemic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 125,
                    "offsetInEndSection": 168,
                    "text": "It is a descriptive, cross-sectional study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 495,
                    "text": "According to operational case definition, suspected yellow fever cases are included in case spread sheet with variables like age, sex, locality, occupation, status of vaccination, onset of symptoms, presenting symptoms, date of blood sampling and confirmation of diagnosis either by laboratory results or epidemiological link."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 496,
                    "offsetInEndSection": 644,
                    "text": "Data about important entomological indices were collected by surveys conducted in 17 localities of 3 Darfur states (Central, West and south Darfur)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 645,
                    "offsetInEndSection": 735,
                    "text": "All Darfur states (especially Central Darfur) have been affected by Yellow Fever outbreak."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 736,
                    "offsetInEndSection": 901,
                    "text": "There is a need to review the non-specific case definition of Yellow Fever which seems to overwhelm the system during outbreaks with cases of other endemic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 902,
                    "offsetInEndSection": 1020,
                    "text": "The significant risk factors of this outbreak included male sex, adult age, outdoor occupation and traditional mining."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1021,
                    "offsetInEndSection": 1092,
                    "text": "The fatality rate was significantly associated with vaccination status."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1093,
                    "offsetInEndSection": 1174,
                    "text": "The highest fatality rate was recorded by children less than 2 years old (42.9%)."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                "http://www.ncbi.nlm.nih.gov/pubmed/16431664",
                "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                "http://www.ncbi.nlm.nih.gov/pubmed/9893853",
                "http://www.ncbi.nlm.nih.gov/pubmed/19493108",
                "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                "http://www.ncbi.nlm.nih.gov/pubmed/4049749",
                "http://www.ncbi.nlm.nih.gov/pubmed/28274040"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Prevalence of Colour Vision Anomalies Amongst Dental Professionals and its Effect on Shade Matching of Teeth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "INTRODUCTION\nThe success of a restoration is dependent on accurate shade matching of teeth leading to studies evaluating the factors affecting the perception of shades."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 352,
                    "text": "Colour vision anomalies including colour blindness have been found to exist in the population and it has been thought to be a potential factor affecting the colour perception ability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 355,
                    "offsetInEndSection": 486,
                    "text": "AIM\nThe present study was done to evaluate the prevalence of colour vision anomalies and its effect on matching of shades of teeth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 732,
                    "text": "MATERIALS AND METHODS\nA total of 147 dental professionals were randomly selected for the study and were first tested for visual acuity using the Snellen's Eye Chart so as to carry on the study with only those operators who had a vision of 6/6."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 733,
                    "offsetInEndSection": 827,
                    "text": "Then, the Ishihara's colour charts were used to test the operators for colour vision handicap."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 828,
                    "offsetInEndSection": 946,
                    "text": "In the last stage of the study, test for accuracy of shade selection was done using the Vitapan Classical shade guide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 947,
                    "offsetInEndSection": 995,
                    "text": "The shade guide tabs were covered to avoid bias."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 996,
                    "offsetInEndSection": 1188,
                    "text": "Percentage was used to calculate the prevalence of colour vision handicap and its effect on matching of shades of teeth as compared to normal vision, which was evaluated using Chi square test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1191,
                    "offsetInEndSection": 1326,
                    "text": "RESULTS\nNineteen operators had colour vision anomalies out of hundred operators and only two operators presented with colour blindness."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                "http://www.ncbi.nlm.nih.gov/pubmed/15183541",
                "http://www.ncbi.nlm.nih.gov/pubmed/25321415",
                "http://www.ncbi.nlm.nih.gov/pubmed/7604203",
                "http://www.ncbi.nlm.nih.gov/pubmed/19942292",
                "http://www.ncbi.nlm.nih.gov/pubmed/25725141",
                "http://www.ncbi.nlm.nih.gov/pubmed/11911835",
                "http://www.ncbi.nlm.nih.gov/pubmed/25733816",
                "http://www.ncbi.nlm.nih.gov/pubmed/16158200"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "MCF-7/ADR cells have been widely used as a multidrug-resistant breast cancer cell model in cancer research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 108,
                    "offsetInEndSection": 221,
                    "text": "The origin of MCF-7/ADR has been a matter of debate since MCF-7/ADR cells were re-designated NCI/ADR-RES in 1998."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 327,
                    "text": "Many recent studies still describe MCF-7/ADR cells as originating from the breast cancer cell line MCF-7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 390,
                    "text": "Thus, the real origin of MCF-7/ADR cells remains more unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 391,
                    "offsetInEndSection": 555,
                    "text": "In this study, a new adriamycin (ADR)-resistant cell line MCF-7/ADR' was reproduced using the same procedure employed during the initial establishment of MCF-7/ADR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 838,
                    "text": "Since the MCF-7/ADR' cell line was definitely derived from parental MCF-7 cells, we were able to directly compare these cell lines together with MCF-7/ADR using immunocytochemical, morphological, and consecutive DNA fingerprinting analyses to determine the true origin of MCF-7/ADR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 839,
                    "offsetInEndSection": 1057,
                    "text": "Both ADR-resistant cell lines displayed some similar phenotypic characteristics, such as high levels of P-glycoprotein (P-gp) expression, increased vacuolation, abundant filamentous material, and irregular pseudopodia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1058,
                    "offsetInEndSection": 1188,
                    "text": "With increasing concentrations of ADR, the DNA fingerprints of MCF-7/ADR' cells were always identical to the parental MCF-7 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1189,
                    "offsetInEndSection": 1276,
                    "text": "However, the DNA fingerprints of MCF-7/ADR cells did not relate to MCF-7 or MCF-7/ADR'."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                "http://www.ncbi.nlm.nih.gov/pubmed/20138170",
                "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                "http://www.ncbi.nlm.nih.gov/pubmed/12381269",
                "http://www.ncbi.nlm.nih.gov/pubmed/11890723",
                "http://www.ncbi.nlm.nih.gov/pubmed/12645630",
                "http://www.ncbi.nlm.nih.gov/pubmed/12128073"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Lumican expression in the stromal tissues of pancreatic ductal adenocarcinoma (PDAC) correlates with tumor invasion, and tends to correlate with poor prognosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 266,
                    "text": "We used gene transfection techniques to examine the biological roles of lumican secreted from PDAC cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 364,
                    "text": "Lumican-transfected PANC-1 cells secreted a 70-kDa lumican protein and had an active ERK pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 365,
                    "offsetInEndSection": 518,
                    "text": "Transfection stimulated PANC-1 cell growth, increased cell adhesion to laminin, inhibited cell invasion, and decreased active matrix metalloproteinase-9."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 519,
                    "offsetInEndSection": 593,
                    "text": "Down-regulation of lumican using siRNA resulted in opposite cell behavior."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 594,
                    "offsetInEndSection": 692,
                    "text": "Thus, the 70-kDa lumican secreted by PDAC cells plays important roles in cell growth and invasion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 216,
                    "text": "The small leucine-rich proteoglycan lumican was identified from a human placenta cDNA library by the expression cloning method as a gene product that interacts with membrane-type matrix metalloproteinase-1 (MT1-MMP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 409,
                    "text": "Coexpression of MT1-MMP with lumican in HEK293T cells reduced the concentration of lumican secreted into culture medium, and this reduction was abolished by addition of the MMP inhibitor BB94."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18799805",
                "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                "http://www.ncbi.nlm.nih.gov/pubmed/10620362",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/23974699",
                "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                "http://www.ncbi.nlm.nih.gov/pubmed/7614688"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Induction of cytochrome P450 3A (CYP3A) has been suggested as a mechanism of action of ursodeoxycholic acid (UDCA) in cholestasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 131,
                    "offsetInEndSection": 311,
                    "text": "CYP3A is of key importance in human drug metabolism, being involved in presystemic extraction of more than 50% of all drugs currently available and of various endogenous compounds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 489,
                    "text": "Therefore, we compared the induction potential of UDCA with that of the prototypical inducer rifampicin in a human model study with the CYP3A substrates budesonide and cortisol."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 490,
                    "offsetInEndSection": 685,
                    "text": "Twelve patients with early-stage primary biliary cirrhosis and eight healthy volunteers were treated with UDCA (15 mg/kg daily) for 3 weeks and subsequently with rifampicin (600 mg/d) for 1 week."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 686,
                    "offsetInEndSection": 937,
                    "text": "Extensive pharmacokinetic profiling of oral budesonide (3 mg) was performed by determination of budesonide and phase I metabolites (6beta-hydroxybudesonide, 16alpha-hydroxyprednisolone) in plasma and urine at baseline and at the end of each treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 938,
                    "offsetInEndSection": 1036,
                    "text": "In parallel, urinary 6beta-hydroxycortisol, a validated marker of CYP3A induction, was determined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1037,
                    "offsetInEndSection": 1180,
                    "text": "UDCA did not affect biotransformation of budesonide and urinary excretion of 6beta-hydroxycortisol either in patients or in healthy volunteers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1181,
                    "offsetInEndSection": 1354,
                    "text": "Ratios of areas under plasma concentration-time curves (AUC(0-12 h) during UDCA/AUC(0-12 h) before UDCA) of both metabolites were not higher than those of budesonide itself."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1355,
                    "offsetInEndSection": 1532,
                    "text": "In contrast, administration of rifampicin markedly induced CYP3A metabolism, resulting in abolished budesonide plasma levels and high urinary excretion of 6beta-hydroxycortisol."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                "http://www.ncbi.nlm.nih.gov/pubmed/7284984",
                "http://www.ncbi.nlm.nih.gov/pubmed/9310467",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                "http://www.ncbi.nlm.nih.gov/pubmed/10470089",
                "http://www.ncbi.nlm.nih.gov/pubmed/3289649",
                "http://www.ncbi.nlm.nih.gov/pubmed/28333343"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "We have recently identified a common ALL patient which harboured a chromosomal fusion between the TEL gene on chromosome 12 and the ABL gene on chromosome 9."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                    "endSection": "abstract",
                    "offsetInBeginSection": 158,
                    "offsetInEndSection": 269,
                    "text": "We designed an RT-PCR assay to screen 186 adult ALL and 30 childhood ALL patients for this novel translocation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                    "endSection": "abstract",
                    "offsetInBeginSection": 270,
                    "offsetInEndSection": 348,
                    "text": "We were unable to identify any additional cases with a TEL/ABL fusion product."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Chromosome-Specific Centromere Sequences Provide an Estimate of the Ancestral Chromosome 2 Fusion Event in Hominin Genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 338,
                    "text": "Genomic signatures of this event are limited to inverted telomeric repeats at the precise site of chromosomal fusion and to the small amount of relic centromeric sequences that remain on 2q21.2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 705,
                    "text": "Unlike the site of fusion, which is enriched for sequences that are shared elsewhere in the human genome, the region of the nonfunctioning and degenerate ancestral centromere appears to share limited similarity with other sites in the human genome, thereby providing an opportunity to study this genomic arrangement in short, fragmented ancient DNA genomic datasets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 706,
                    "offsetInEndSection": 841,
                    "text": "Here, chromosome-assigned satellite DNAs are used to study shared centromere sequence organization in Denisovan and Neandertal genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 842,
                    "offsetInEndSection": 1239,
                    "text": "By doing so, one is able to provide evidence for the presence of both active and degenerate centromeric satellite profiles on chromosome 2 in these archaic genomes, supporting the hypothesis that the chromosomal fusion event took place prior to our last common ancestor with Denisovan and Neandertal hominins and presenting a genomic reference for predicting karyotype in ancient genomic datasets."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                "http://www.ncbi.nlm.nih.gov/pubmed/16054130",
                "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                "http://www.ncbi.nlm.nih.gov/pubmed/15555457",
                "http://www.ncbi.nlm.nih.gov/pubmed/20593890",
                "http://www.ncbi.nlm.nih.gov/pubmed/29245156",
                "http://www.ncbi.nlm.nih.gov/pubmed/19276185",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388758"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Analysis of EPCAM protein expression in diagnostics of Lynch syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "PURPOSE\nLynch syndrome is an inherited tumor predisposition syndrome caused by germline mutations of DNA mismatch repair (MMR) genes, mainly MLH1 and MSH2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 399,
                    "text": "Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel mutational mechanism causing Lynch syndrome by epigenetic inactivation of the respective MSH2 allele."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 585,
                    "text": "Immunohistochemical analysis of MMR protein expression is a hallmark of Lynch syndrome diagnostics, but it cannot distinguish between EPCAM deletion carriers and MSH2 mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 704,
                    "text": "We hypothesized that EPCAM protein expression might be altered in tumors from patients with a germline EPCAM deletion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 707,
                    "offsetInEndSection": 844,
                    "text": "PATIENTS AND METHODS\nImmunohistochemistry was used to assess EPCAM expression in Lynch syndrome-associated MSH2-negative tumors (n = 26)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 845,
                    "offsetInEndSection": 985,
                    "text": "Multiplex ligation-dependent probe amplification (MLPA) analysis was performed to detect germline deletions of the EPCAM and MSH2 gene loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1078,
                    "text": "RESULTS\nIn four MSH2-negative tumors, a concomitant lack of EPCAM expression was detected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1174,
                    "text": "MLPA analysis revealed heterozygous EPCAM deletions in all patients with EPCAM-negative tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1175,
                    "offsetInEndSection": 1302,
                    "text": "In contrast, EPCAM expression was positive in all cancers from patients with germline alterations affecting MSH2 but not EPCAM."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                "http://www.ncbi.nlm.nih.gov/pubmed/26298448",
                "http://www.ncbi.nlm.nih.gov/pubmed/23305476",
                "http://www.ncbi.nlm.nih.gov/pubmed/24672216",
                "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                "http://www.ncbi.nlm.nih.gov/pubmed/27984753",
                "http://www.ncbi.nlm.nih.gov/pubmed/25195485",
                "http://www.ncbi.nlm.nih.gov/pubmed/22533680"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "[Management of major bleeding complications in patients on long-term treatment with oral anticoagulants]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 332,
                    "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 441,
                    "text": "Given their ease of use, it is expected that these drugs would be widely used in such long-term indications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 442,
                    "offsetInEndSection": 651,
                    "text": "Beyond their effectiveness, these treatments remain anticoagulant drugs, potentially responsible for bleeding complications, and specific measures should be defined in case of occurrence of such complications."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 202,
                    "offsetInEndSection": 413,
                    "text": "However, many physicians are wary of these drugs, since there is limited evidence on how to manage bleeding in patients taking them, and since no specific antidote is known to reverse their anticoagulant effect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 414,
                    "offsetInEndSection": 489,
                    "text": "Management requires careful adherence to first principles of bleeding care."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 490,
                    "offsetInEndSection": 593,
                    "text": "Unapproved and untested reversal strategies may be required in patients with life-threatening bleeding."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27984753",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Validated spectrofluorimetric methods for the determination of apixaban and tirofiban hydrochloride in pharmaceutical formulations."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                "http://www.ncbi.nlm.nih.gov/pubmed/24833492",
                "http://www.ncbi.nlm.nih.gov/pubmed/28750496",
                "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                "http://www.ncbi.nlm.nih.gov/pubmed/27683159",
                "http://www.ncbi.nlm.nih.gov/pubmed/26802556",
                "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                "http://www.ncbi.nlm.nih.gov/pubmed/28790016",
                "http://www.ncbi.nlm.nih.gov/pubmed/25358680"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 47,
                    "text": "Tau PET imaging: present and future directions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Abnormal aggregation of tau in the brain is a major contributing factor in various neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 197,
                    "text": "The role of tau phosphorylation in the pathophysiology of tauopathies remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 198,
                    "offsetInEndSection": 324,
                    "text": "Consequently, it is important to be able to accurately and specifically target tau deposits in vivo in the brains of patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 536,
                    "text": "The advances of molecular imaging in the recent years have now led to the recent development of promising tau-specific tracers for positron emission tomography (PET), such as THK5317, THK5351, AV-1451, and PBB3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 537,
                    "offsetInEndSection": 693,
                    "text": "These tracers are now available for clinical assessment in patients with various tauopathies, including Alzheimer's disease, as well as in healthy subjects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 694,
                    "offsetInEndSection": 902,
                    "text": "Exploring the patterns of tau deposition in vivo for different pathologies will allow discrimination between neurodegenerative diseases, including different tauopathies, and monitoring of disease progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1078,
                    "text": "The variety and complexity of the different types of tau deposits in the different diseases, however, has resulted in quite a challenge for the development of tau PET tracers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1261,
                    "text": "Extensive work remains in order to fully characterize the binding properties of the tau PET tracers, and to assess their usefulness as an early biomarker of the underlying pathology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1262,
                    "offsetInEndSection": 1492,
                    "text": "In this review, we summarize recent findings on the most promising tau PET tracers to date, discuss what has been learnt from these findings, and offer some suggestions for the next steps that need to be achieved in a near future."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                "http://www.ncbi.nlm.nih.gov/pubmed/19762763",
                "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                "http://www.ncbi.nlm.nih.gov/pubmed/20832171",
                "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                "http://www.ncbi.nlm.nih.gov/pubmed/16492837",
                "http://www.ncbi.nlm.nih.gov/pubmed/23308208",
                "http://www.ncbi.nlm.nih.gov/pubmed/9803050"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "The formalin test in mice: effect of formalin concentration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "The effect of different formalin concentrations on the nociceptive response in the formalin test was examined in mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 299,
                    "text": "Subcutaneous formalin injection induces 2 distinct periods of high licking activity: an early phase lasting the first 5 min, and a late phase lasting 20-30 min after the injection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 450,
                    "text": "Formalin concentrations of 0.02-0.2% induced only the early phase, while concentrations of 1% or more induced both the early phase and the late phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 600,
                    "text": "The ability of the test to show the antinociceptive effect of morphine and acetylsalicylic acid was similar for high and low formalin concentrations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 601,
                    "offsetInEndSection": 758,
                    "text": "For both these analgesics, a lower dose was needed to induce antinociception in the late phase than in the early phase using the same formalin concentration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 759,
                    "offsetInEndSection": 805,
                    "text": "Indomethacin had no effect in the early phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 806,
                    "offsetInEndSection": 947,
                    "text": "In the late phase indomethacin induced antinociception when 1% formalin was used, while no significant effect was observed using 5% formalin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 948,
                    "offsetInEndSection": 1059,
                    "text": "Clear histological changes in the paw were demonstrated after formalin concentrations that induced both phases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1060,
                    "offsetInEndSection": 1122,
                    "text": "Lower formalin concentrations induced only very small changes."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                "http://www.ncbi.nlm.nih.gov/pubmed/21082060",
                "http://www.ncbi.nlm.nih.gov/pubmed/8447556",
                "http://www.ncbi.nlm.nih.gov/pubmed/27495842",
                "http://www.ncbi.nlm.nih.gov/pubmed/19830087",
                "http://www.ncbi.nlm.nih.gov/pubmed/28614233",
                "http://www.ncbi.nlm.nih.gov/pubmed/25230268",
                "http://www.ncbi.nlm.nih.gov/pubmed/28357164",
                "http://www.ncbi.nlm.nih.gov/pubmed/19683136"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Resolution of spontaneous spinal epidural hematoma without surgery: report of two cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 25,
                    "text": "STUDY DESIGN\nCase report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 28,
                    "offsetInEndSection": 184,
                    "text": "OBJECTIVE\nTo report two cases of spontaneous spinal epidural hematoma that completely resolved, clinically and radiographically, without surgical treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 187,
                    "offsetInEndSection": 276,
                    "text": "SUMMARY OF BACKGROUND DATA\nThe treatment of spinal epidural hematoma is usually surgical."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 370,
                    "text": "Spontaneous spinal epidural hematoma is an uncommon phenomenon and may be of uncertain cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 373,
                    "offsetInEndSection": 548,
                    "text": "METHODS\nOne patient with acute onset of complete quadriplegia and another with complete paraplegia caused by spontaneous spinal epidural hematoma were treated without surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 551,
                    "offsetInEndSection": 664,
                    "text": "RESULTS\nBoth patients recovered nearly completely with respect to their neurologic function at 3-month follow-up."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 665,
                    "offsetInEndSection": 707,
                    "text": "No source of hematoma was ever identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 710,
                    "offsetInEndSection": 883,
                    "text": "CONCLUSIONS\nSpontaneous spinal epidural hematoma should be considered in the differential diagnosis of sudden onset of spinal cord compression in association with back pain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 884,
                    "offsetInEndSection": 1079,
                    "text": "Patients initially presenting with severe neurologic dysfunction are potential candidates for conservative management if they demonstrate rapid and progressive improvement in neurologic function."
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                "http://www.ncbi.nlm.nih.gov/pubmed/7581375",
                "http://www.ncbi.nlm.nih.gov/pubmed/9536081",
                "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                "http://www.ncbi.nlm.nih.gov/pubmed/21933837",
                "http://www.ncbi.nlm.nih.gov/pubmed/9536080",
                "http://www.ncbi.nlm.nih.gov/pubmed/7604023",
                "http://www.ncbi.nlm.nih.gov/pubmed/11200958",
                "http://www.ncbi.nlm.nih.gov/pubmed/19692580",
                "http://www.ncbi.nlm.nih.gov/pubmed/21610160"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Four inherited neurodegenerative diseases are linked to abnormally expanded repeats of glutamine residues in the affected proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 132,
                    "offsetInEndSection": 318,
                    "text": "Molecular modeling followed by optical, electron, and x-ray diffraction studies of a synthetic poly(L-glutamine) shows that it forms beta-sheets strongly held together by hydrogen bonds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 454,
                    "text": "Glutamine repeats may function as polar zippers, for example, by joining specific transcription factors bound to separate DNA segments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 455,
                    "offsetInEndSection": 616,
                    "text": "Their extension may cause disease either by increased, nonspecific affinity between such factors or by gradual precipitation of the affected proteins in neurons."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Eight diseases are now known to be caused by an expansion mutation of the trinucleotide repeat CAG encoding glutamine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 119,
                    "offsetInEndSection": 267,
                    "text": "Each disease is caused by a CAG expansion in a different gene, and the genes bear no similarity to each other except for the presence of the repeat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 268,
                    "offsetInEndSection": 407,
                    "text": "Nonetheless, the essential feature of all of these disorders is neurodegeneration in a set of overlapping cortical and subcortical regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 408,
                    "offsetInEndSection": 491,
                    "text": "Disease age of onset, and in some cases severity, is correlated with repeat length."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                "http://www.ncbi.nlm.nih.gov/pubmed/25559185",
                "http://www.ncbi.nlm.nih.gov/pubmed/26883443",
                "http://www.ncbi.nlm.nih.gov/pubmed/28424353",
                "http://www.ncbi.nlm.nih.gov/pubmed/26798136",
                "http://www.ncbi.nlm.nih.gov/pubmed/24717229",
                "http://www.ncbi.nlm.nih.gov/pubmed/8216425",
                "http://www.ncbi.nlm.nih.gov/pubmed/25784758"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Dynamic interactions of nuclear lamins with chromatin through lamin-associated domains (LADs) contribute to spatial arrangement of the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 378,
                    "text": "Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 379,
                    "offsetInEndSection": 726,
                    "text": "We demonstrate a two-step process of lamin A/C LAD formation during in vitro adipogenesis, involving spreading of lamin A/C-chromatin interactions in the transition from progenitor cell proliferation to cell-cycle arrest, and genome-scale redistribution of these interactions through a process of LAD exchange within hours of adipogenic induction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 727,
                    "offsetInEndSection": 855,
                    "text": "Lamin A/C LADs are found both in active and repressive chromatin contexts that can be influenced by cell differentiation status."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1006,
                    "text": "De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1007,
                    "offsetInEndSection": 1159,
                    "text": "Accordingly, whereas predifferentiation lamin A/C LADs are gene-rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1 LADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1160,
                    "offsetInEndSection": 1377,
                    "text": "Release of lamin A/C from genes directly involved in glycolysis concurs with their transcriptional up-regulation after adipogenic induction, and with downstream elevations in H2BS112GlcNAc levels and O-GlcNAc cycling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1378,
                    "offsetInEndSection": 1586,
                    "text": "Our results unveil an epigenetic prepatterning of adipogenic LADs by GADs, suggesting a coupling of developmentally regulated lamin A/C-genome interactions to a metabolically sensitive chromatin modification."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Distinct features of lamin A-interacting chromatin domains mapped by ChIP-sequencing from sonicated or micrococcal nuclease-digested chromatin."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                "http://www.ncbi.nlm.nih.gov/pubmed/2571614",
                "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                "http://www.ncbi.nlm.nih.gov/pubmed/11943181",
                "http://www.ncbi.nlm.nih.gov/pubmed/11795487",
                "http://www.ncbi.nlm.nih.gov/pubmed/8440257",
                "http://www.ncbi.nlm.nih.gov/pubmed/11460887",
                "http://www.ncbi.nlm.nih.gov/pubmed/7674375"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 64,
                    "text": "New clathrin-based nanoplatforms for magnetic resonance imaging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "BACKGROUND\nMagnetic Resonance Imaging (MRI) has high spatial resolution, but low sensitivity for visualization of molecular targets in the central nervous system (CNS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 270,
                    "text": "Our goal was to develop a new MRI method with the potential for non-invasive molecular brain imaging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 404,
                    "text": "We herein introduce new bio-nanotechnology approaches for designing CNS contrast media based on the ubiquitous clathrin cell protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 539,
                    "text": "METHODOLOGY/PRINCIPAL FINDINGS\nThe first approach utilizes three-legged clathrin triskelia modified to carry 81 gadolinium chelates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 540,
                    "offsetInEndSection": 656,
                    "text": "The second approach uses clathrin cages self-assembled from triskelia and designed to carry 432 gadolinium chelates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 657,
                    "offsetInEndSection": 784,
                    "text": "Clathrin triskelia and cages were characterized by size, structure, protein concentration, and chelate and gadolinium contents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 785,
                    "offsetInEndSection": 1050,
                    "text": "Relaxivity was evaluated at 0.47 T. A series of studies were conducted to ascertain whether fluorescent-tagged clathrin nanoplatforms could cross the blood brain barriers (BBB) unaided following intranasal, intravenous, and intraperitoneal routes of administration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1051,
                    "offsetInEndSection": 1166,
                    "text": "Clathrin nanoparticles can be constituted as triskelia (18.5 nm in size), and as cages assembled from them (55 nm)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1167,
                    "offsetInEndSection": 1276,
                    "text": "The mean chelate: clathrin heavy chain molar ratio was 27.04\u00b14.8: 1 for triskelia, and 4.2\u00b11.04: 1 for cages."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                "http://www.ncbi.nlm.nih.gov/pubmed/6191815",
                "http://www.ncbi.nlm.nih.gov/pubmed/22102008",
                "http://www.ncbi.nlm.nih.gov/pubmed/4141622",
                "http://www.ncbi.nlm.nih.gov/pubmed/21401967",
                "http://www.ncbi.nlm.nih.gov/pubmed/26776480",
                "http://www.ncbi.nlm.nih.gov/pubmed/2478578",
                "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                "http://www.ncbi.nlm.nih.gov/pubmed/12605409",
                "http://www.ncbi.nlm.nih.gov/pubmed/6193441"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "Validating myelin water imaging with transmission electron microscopy in a rat spinal cord injury model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Myelin content is an important marker for neuropathology and MRI generated myelin water fraction (MWF) has been shown to correlate well with myelin content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 157,
                    "offsetInEndSection": 344,
                    "text": "However, because MWF is based on the amount of signal from myelin water, that is, the water trapped between the myelin lipid bilayers, the reading may depend heavily on myelin morphology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 345,
                    "offsetInEndSection": 453,
                    "text": "This is of special concern when there is a mix of intact myelin and myelin debris, as in the case of injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 649,
                    "text": "To investigate what MWF measures in the presence of debris, we compared MWF to transmission electron microscopy (TEM) derived myelin fraction that measures the amount of compact appearing myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 650,
                    "offsetInEndSection": 830,
                    "text": "A rat spinal cord injury model was used with time points at normal (normal myelin), 3 weeks post-injury (myelin debris), and 8 weeks post-injury (myelin debris, partially cleared)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 831,
                    "offsetInEndSection": 1047,
                    "text": "The myelin period between normal and 3 or 8 weeks post-injury cords did not differ significantly, suggesting that as long as the bilayer structure is intact, myelin debris has the same water content as intact myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1048,
                    "offsetInEndSection": 1227,
                    "text": "The MWF also correlated strongly with the TEM-derived myelin fraction, suggesting that MWF measures the amount of compact appearing myelin in both intact myelin and myelin debris."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1228,
                    "offsetInEndSection": 1391,
                    "text": "From the TEM images, it appears that as myelin degenerates, it tends to form large watery spaces within the myelin sheaths that are not classified as myelin water."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1392,
                    "offsetInEndSection": 1531,
                    "text": "The results presented in this study improve our understanding and allows for better interpretation of MWF in the presence of myelin debris."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                "http://www.ncbi.nlm.nih.gov/pubmed/17296251",
                "http://www.ncbi.nlm.nih.gov/pubmed/23942901",
                "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                "http://www.ncbi.nlm.nih.gov/pubmed/16368972",
                "http://www.ncbi.nlm.nih.gov/pubmed/18390151",
                "http://www.ncbi.nlm.nih.gov/pubmed/16739129",
                "http://www.ncbi.nlm.nih.gov/pubmed/10941733"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Mouse cytokine profile skewed towards Th2 in pregnancy during infection with Brucella abortus S19 strain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The two classes of cytokines Th1 and Th2 determine the type of immune response elicited."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 89,
                    "offsetInEndSection": 153,
                    "text": "The Th2 immune response is associated with successful pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 290,
                    "text": "Brucellosis is an intracellular bacterium that elicits the Th1 response and is known to cause spontaneous abortion in mammalian species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 449,
                    "text": "This study sought to determine if Brucella infection causes spontaneous abortion by causing the circulating cytokine profile be Th1 dominant during pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 584,
                    "text": "Forty-eight Swiss white mice were used in this murine model and the S19 strain of Brucella abortus was used in as the infective agent."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 585,
                    "offsetInEndSection": 748,
                    "text": "Pregnant mice in the test group were injected intraperitoneally with 10(5-8) CFU of Brucella and cytokine profile evaluated over the three trimesters of pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 749,
                    "offsetInEndSection": 901,
                    "text": "Pregnant mice in the control group were left to go through normal pregnancy and their cytokine profile evaluated over the three trimesters of pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 902,
                    "offsetInEndSection": 968,
                    "text": "Cytokines in serum samples were analyzed by Cytometric Bead Array."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 969,
                    "offsetInEndSection": 1056,
                    "text": "The data was analyzed using the Paired T- test and p < 0.05 was considered significant."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                "http://www.ncbi.nlm.nih.gov/pubmed/14745010",
                "http://www.ncbi.nlm.nih.gov/pubmed/23914934",
                "http://www.ncbi.nlm.nih.gov/pubmed/11484052"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "Evaluating Neanderthal genetics and phylogeny."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 247,
                    "offsetInEndSection": 407,
                    "text": "Recently, however, both the authenticity of the Neanderthal sequences and their phylogenetic position outside contemporary human diversity have been questioned."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 408,
                    "offsetInEndSection": 669,
                    "text": "Using Bayesian inference and the largest dataset to date, we find strong support for a monophyletic Neanderthal clade outside the diversity of contemporary humans, in agreement with the expectations of the Out-of-Africa replacement model of modern human origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 670,
                    "offsetInEndSection": 867,
                    "text": "From average pairwise sequence differences, we obtain support for claims that the first published Neanderthal sequence may include errors due to postmortem damage in the template molecules for PCR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1139,
                    "text": "In contrast, we find that recent results implying that the Neanderthal sequences are products of PCR artifacts are not well supported, suffering from inadequate experimental design and a presumably high percentage (>68%) of chimeric sequences due to \"jumping PCR\" events."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Dental evidence for ontogenetic differences between modern humans and Neanderthals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Humans have an unusual life history, with an early weaning age, long childhood, late first reproduction, short interbirth intervals, and long lifespan."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                    "endSection": "abstract",
                    "offsetInBeginSection": 152,
                    "offsetInEndSection": 248,
                    "text": "In contrast, great apes wean later, reproduce earlier, and have longer intervals between births."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                    "endSection": "abstract",
                    "offsetInBeginSection": 249,
                    "offsetInEndSection": 353,
                    "text": "Despite 80 y of speculation, the origins of these developmental patterns in Homo sapiens remain unknown."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                "http://www.ncbi.nlm.nih.gov/pubmed/21935843",
                "http://www.ncbi.nlm.nih.gov/pubmed/22872850",
                "http://www.ncbi.nlm.nih.gov/pubmed/10409813",
                "http://www.ncbi.nlm.nih.gov/pubmed/18453667",
                "http://www.ncbi.nlm.nih.gov/pubmed/734986",
                "http://www.ncbi.nlm.nih.gov/pubmed/8501389",
                "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                "http://www.ncbi.nlm.nih.gov/pubmed/190288"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Rheumatoid arthritis and Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Of four patients with rheumatoid arthritis and Dupuytren's contracture, two were not aware of the presence of Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "abstract",
                    "offsetInBeginSection": 135,
                    "offsetInEndSection": 347,
                    "text": "When both diseases coexist, the presence of rheumatoid hand deformities, especially flexion and ulnar deviation of the metacarpophalangeal joints, may mask the flexion deformity caused by Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 435,
                    "text": "Careful clinical examination should rule out the presence of a pathologic fascial cord."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 665,
                    "text": "When reconstructive surgery is indicated for the rheumatoid hand in the presence of advanced Dupuytren's contracture, staged surgery would be appropriate and reconstruction of Dupuytren's contracture should precede other surgery."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 42,
                    "text": "Free radicals and Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 207,
                    "text": "The concentration of substrate expressed as hypoxanthine capable of reacting with xanthine oxidase to release superoxide free radicals (O2-) was measured in control and Dupuytren's contracture palmar fascia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 349,
                    "text": "In Dupuytren's contracture palmar fascia the concentration of hypoxanthine was six times that of control and was greatest in \"nodular\" areas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 350,
                    "offsetInEndSection": 435,
                    "text": "Xanthine oxidase activity was also detected in Dupuytren's contracture palmar fascia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2825907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 609,
                    "text": "These results suggest a greater potential for hypoxanthine-xanthine oxidase generated oxygen free radical formation in Dupuytren's contracture than in control palmar fascia."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                "http://www.ncbi.nlm.nih.gov/pubmed/25794181",
                "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                "http://www.ncbi.nlm.nih.gov/pubmed/16567973",
                "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                "http://www.ncbi.nlm.nih.gov/pubmed/26103569",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637132",
                "http://www.ncbi.nlm.nih.gov/pubmed/22547573",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030758"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nCarrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associated with a high risk for melanoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 348,
                    "text": "Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and some variants of the melanocortin-1 receptor gene (MC1R), which is known to have a role in the pigmentation process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 349,
                    "offsetInEndSection": 470,
                    "text": "However, investigation of the associations of both MC1R variants and host phenotypes with melanoma risk has been limited."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 473,
                    "offsetInEndSection": 699,
                    "text": "METHODS\nWe included 815 CDKN2A mutation carriers (473 affected, and 342 unaffected, with melanoma) from 186 families from 15 centers in Europe, North America, and Australia who participated in the Melanoma Genetics Consortium."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 700,
                    "offsetInEndSection": 1019,
                    "text": "In this family-based study, we assessed the associations of the four most frequent MC1R variants (V60L, V92M, R151C, and R160W) and the number of variants (1, \u22652 variants), alone or jointly with the host phenotypes (hair color, propensity to sunburn, and number of nevi), with melanoma risk in CDKN2A mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1020,
                    "offsetInEndSection": 1104,
                    "text": "These associations were estimated and tested using generalized estimating equations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1105,
                    "offsetInEndSection": 1142,
                    "text": "All statistical tests were two-sided."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1393,
                    "text": "RESULTS\nCarrying any one of the four most frequent MC1R variants (V60L, V92M, R151C, R160W) in CDKN2A mutation carriers was associated with a statistically significantly increased risk for melanoma across all continents (1.24 \u00d7 10(-6) \u2264 P \u2264 .0007)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1394,
                    "offsetInEndSection": 1505,
                    "text": "A consistent pattern of increase in melanoma risk was also associated with increase in number of MC1R variants."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                "http://www.ncbi.nlm.nih.gov/pubmed/23895768",
                "http://www.ncbi.nlm.nih.gov/pubmed/20887736",
                "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                "http://www.ncbi.nlm.nih.gov/pubmed/21708948",
                "http://www.ncbi.nlm.nih.gov/pubmed/10378263"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "Subdomain architecture and stability of a giant repeat protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 229,
                    "text": "Tandem repeat proteins, which are widespread in the human genome, tend to exhibit high stability and favorable expression, and hence, they are emerging as promising protein scaffolds in alternative to antibodies in biotechnology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 462,
                    "text": "In order to investigate the origin of the stability of these proteins, we dissect the subdomain architecture of the giant repeat protein PR65/A, which comprises 15 \u03b1-helical HEAT repeats, using a series of truncations and deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 463,
                    "offsetInEndSection": 756,
                    "text": "We find that the N (HEAT 1-2) and the C (HEAT 14-15) subdomains are not capable of independent folding, but the addition of HEAT 13 to HEAT 14-15 results in an independently stable C-terminal subdomain (HEAT 13-15), which is in turn further stabilized by the inclusion of HEAT 12 (HEAT 12-15)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 757,
                    "offsetInEndSection": 964,
                    "text": "We also further show that the stability of HEAT 13-15 is enhanced by its fusion to HEAT 1-2, and the artificial 5-HEAT-repeat protein thereby created (HEAT NC) behaves like a cooperative multidomain protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 965,
                    "offsetInEndSection": 1237,
                    "text": "We construct further variants, lacking one or both of the terminal subdomains, and find that such subdomains function as stabilizing caps within full-length PR65/A as in their absence, the central subdomain of the protein unfolds to form non-native \u03b2-sheet-like oligomers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1238,
                    "offsetInEndSection": 1468,
                    "text": "Taken together, our results suggest that in full-length PR65/A, the more unstable regions within the central repeats are protected by the adjacent folded repeats, which thus act as gatekeepers by virtue of their greater stability."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Highly sensitive detection of individual HEAT and ARM repeats with HHpred and COACH."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "BACKGROUND\nHEAT and ARM repeats occur in a large number of eukaryotic proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 181,
                    "text": "As these repeats are often highly diverged, the prediction of HEAT or ARM domains can be challenging."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                "http://www.ncbi.nlm.nih.gov/pubmed/19151744",
                "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                "http://www.ncbi.nlm.nih.gov/pubmed/16081639",
                "http://www.ncbi.nlm.nih.gov/pubmed/6643499",
                "http://www.ncbi.nlm.nih.gov/pubmed/16925598",
                "http://www.ncbi.nlm.nih.gov/pubmed/26599052",
                "http://www.ncbi.nlm.nih.gov/pubmed/9143349",
                "http://www.ncbi.nlm.nih.gov/pubmed/27684355"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "Analysis of Protein Stability by the Cycloheximide Chase Assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "Comparison of protein stability in eukaryotic cells has been achieved by cycloheximide, which is an inhibitor of protein biosynthesis due to its prevention in translational elongation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 185,
                    "offsetInEndSection": 327,
                    "text": "It is broadly used in cell biology in terms of determining the half-life of a given protein and has gained much popularity in cancer research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 452,
                    "text": "Here we present a full cycloheximide chase assay in our laboratory using a lung adenocarcinoma cell line, CL1-5, as a model."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Regulation of protein abundance is crucial to virtually every cellular process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 181,
                    "text": "Protein abundance reflects the integration of the rates of protein synthesis and protein degradation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 443,
                    "text": "Many assays reporting on protein abundance (e.g., single-time point western blotting, flow cytometry, fluorescence microscopy, or growth-based reporter assays) do not allow discrimination of the relative effects of translation and proteolysis on protein levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 648,
                    "text": "This article describes the use of cycloheximide chase followed by western blotting to specifically analyze protein degradation in the model unicellular eukaryote, Saccharomyces cerevisiae (budding yeast)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 649,
                    "offsetInEndSection": 755,
                    "text": "In this procedure, yeast cells are incubated in the presence of the translational inhibitor cycloheximide."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                "http://www.ncbi.nlm.nih.gov/pubmed/27348448",
                "http://www.ncbi.nlm.nih.gov/pubmed/27756426",
                "http://www.ncbi.nlm.nih.gov/pubmed/28862274",
                "http://www.ncbi.nlm.nih.gov/pubmed/19111177",
                "http://www.ncbi.nlm.nih.gov/pubmed/23376832",
                "http://www.ncbi.nlm.nih.gov/pubmed/26941033",
                "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                "http://www.ncbi.nlm.nih.gov/pubmed/26500074"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Maximizing exosome colloidal stability following electroporation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "Development of exosome-based semisynthetic nanovesicles for diagnostic and therapeutic purposes requires novel approaches to load exosomes with cargo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 218,
                    "text": "Electroporation has previously been used to load exosomes with RNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 219,
                    "offsetInEndSection": 327,
                    "text": "However, investigations into exosome colloidal stability following electroporation have not been considered."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 463,
                    "text": "Herein, we report the development of a unique trehalose pulse media (TPM) that minimizes exosome aggregation following electroporation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 464,
                    "offsetInEndSection": 689,
                    "text": "Dynamic light scattering (DLS) and RNA absorbance were employed to determine the extent of exosome aggregation and electroextraction post electroporation in TPM compared to common PBS pulse media or sucrose pulse media (SPM)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 690,
                    "offsetInEndSection": 828,
                    "text": "Use of TPM to disaggregate melanoma exosomes post electroporation was dependent on both exosome concentration and electric field strength."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 829,
                    "offsetInEndSection": 977,
                    "text": "TPM maximized exosome dispersal post electroporation for both homogenous B16 melanoma and heterogeneous human serum-derived populations of exosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 978,
                    "offsetInEndSection": 1226,
                    "text": "Moreover, TPM enabled heavy cargo loading of melanoma exosomes with 5nm superparamagnetic iron oxide nanoparticles (SPION5) while maintaining original exosome size and minimizing exosome aggregation as evidenced by transmission electron microscopy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1227,
                    "offsetInEndSection": 1303,
                    "text": "Loading exosomes with SPION5 increased exosome density on sucrose gradients."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                "http://www.ncbi.nlm.nih.gov/pubmed/12610136",
                "http://www.ncbi.nlm.nih.gov/pubmed/24429298",
                "http://www.ncbi.nlm.nih.gov/pubmed/21457775",
                "http://www.ncbi.nlm.nih.gov/pubmed/21326370",
                "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                "http://www.ncbi.nlm.nih.gov/pubmed/24847042",
                "http://www.ncbi.nlm.nih.gov/pubmed/25635462"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Fast evolution of core promoters in primate genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "Despite much interest in regulatory evolution, how promoters have evolved remains poorly studied, mainly owing to paucity of data on promoter regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 370,
                    "text": "Using a new set of high-quality experimentally determined core promoters of the human genome, we conducted a comparative analysis of 2,492 human and rhesus macaque promoters and their neighboring nearly neutral regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 371,
                    "offsetInEndSection": 689,
                    "text": "We found that the core promoters have an average rate of nucleotide substitution substantially higher than that at 4-fold degenerate sites and only slightly lower than that for the assumed neutral controls of neighboring noncoding regions, suggesting that core promoters are subject to very weak selective constraints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 690,
                    "offsetInEndSection": 905,
                    "text": "Interestingly, we identified 24 core promoters (at false discovery rate = 50%) that have evolved at an accelerated rate compared with the neutral controls, suggesting that they may have undergone positive selection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 906,
                    "offsetInEndSection": 984,
                    "text": "The inferred positively selected genes show strong bias in molecular function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 985,
                    "offsetInEndSection": 1146,
                    "text": "We also used population genetic approaches to examine the evolution of core promoters in human populations and found evidence of positive selection at some loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1147,
                    "offsetInEndSection": 1296,
                    "text": "Taken together, our results suggest that positive selection has played a substantial role in the evolution of transcriptional regulation in primates."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Independence and interdependence of the three human aldolase A promoters in transgenic mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "The human aldolase A gene is transcribed from three alternative promoters, clustered in a small 1.6-kb DNA domain."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                "http://www.ncbi.nlm.nih.gov/pubmed/12516682",
                "http://www.ncbi.nlm.nih.gov/pubmed/25485923",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351313",
                "http://www.ncbi.nlm.nih.gov/pubmed/28314985",
                "http://www.ncbi.nlm.nih.gov/pubmed/27292781",
                "http://www.ncbi.nlm.nih.gov/pubmed/23455714",
                "http://www.ncbi.nlm.nih.gov/pubmed/23790307",
                "http://www.ncbi.nlm.nih.gov/pubmed/27626268",
                "http://www.ncbi.nlm.nih.gov/pubmed/25523529"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 56,
                    "offsetInEndSection": 185,
                    "text": "Treatment with anticoagulants in patients with atrial fibrillation reduces embolic complications of the disease including stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 380,
                    "text": "However, the commonly used anticoagulant has a narrow therapeutic index, requires routine monitoring, and has numerous drug and food interactions leading to less than optimal rates of adherence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 623,
                    "text": "Inhibition of clotting factor Xa has been evaluated as a potential target for anticoagulation therapy with the hypothesis that using target-specific therapy will alleviate some of the dosing variability observed with the vitamin K antagonist."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 624,
                    "offsetInEndSection": 718,
                    "text": "Three factor Xa inhibitors are currently indicated for use in nonvalvular atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 719,
                    "offsetInEndSection": 822,
                    "text": "Similar to the vitamin K antagonist, warfarin, all of the factor Xa inhibitors are administered orally."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 905,
                    "text": "Rivaroxaban and edoxaban are dosed once daily while apixaban is dosed twice daily."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 906,
                    "offsetInEndSection": 1049,
                    "text": "All three agents have demonstrated noninferiority when compared with current standard treatment with warfarin for efficacy and safety outcomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1050,
                    "offsetInEndSection": 1124,
                    "text": "The therapeutic dose of factor Xa inhibitors vary based on renal function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1125,
                    "offsetInEndSection": 1282,
                    "text": "Unlike warfarin, there are no currently available antidotes for the factor Xa inhibitors although this is an area of interest for current and future studies."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                "http://www.ncbi.nlm.nih.gov/pubmed/28425111",
                "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                "http://www.ncbi.nlm.nih.gov/pubmed/11851893",
                "http://www.ncbi.nlm.nih.gov/pubmed/14675180",
                "http://www.ncbi.nlm.nih.gov/pubmed/25454730",
                "http://www.ncbi.nlm.nih.gov/pubmed/10652001",
                "http://www.ncbi.nlm.nih.gov/pubmed/21674528",
                "http://www.ncbi.nlm.nih.gov/pubmed/19945614"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 75,
                    "text": "Plectin is one of the largest and most versatile cytolinker proteins known."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 76,
                    "offsetInEndSection": 185,
                    "text": "In basal keratinocytes it links the intermediate filament network to cell membrane-associated hemidesmosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 318,
                    "text": "Several mutations in its gene have been identified that lead to the recessive disease epidermolysis bullosa with muscular dystrophy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 426,
                    "text": "We report here a mutation that leads to a dominant form of the disease, epidermolysis bullosa simplex Ogna."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 427,
                    "offsetInEndSection": 562,
                    "text": "We found that the epidermolysis bullosa simplex Ogna phenotype is due to a site-specific missense mutation within plectin's rod domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 563,
                    "offsetInEndSection": 691,
                    "text": "Further, we show that epidermolysis bullosa simplex Ogna is not restricted to a single Norwegian kindred as previously believed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 825,
                    "text": "A German family with the phenotypic hallmarks of epidermolysis bullosa simplex Ogna was found to carry an identical de novo mutation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 826,
                    "offsetInEndSection": 878,
                    "text": "These two mutations arose about 200 y apart in time."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 879,
                    "offsetInEndSection": 1104,
                    "text": "Consistent with the absence of muscular symptoms in these patients, muscle biopsies from several epidermolysis bullosa simplex Ogna members of the Norwegian kindred showed normal staining patterns using antibodies to plectin."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                "http://www.ncbi.nlm.nih.gov/pubmed/10359893",
                "http://www.ncbi.nlm.nih.gov/pubmed/22906983",
                "http://www.ncbi.nlm.nih.gov/pubmed/17468237",
                "http://www.ncbi.nlm.nih.gov/pubmed/24903914",
                "http://www.ncbi.nlm.nih.gov/pubmed/16141514",
                "http://www.ncbi.nlm.nih.gov/pubmed/24382176"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 50,
                    "text": "Different approaches to study mast cell functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 189,
                    "text": "Mast cells have long been known to play a detrimental role in the pathogenesis of IgE-associated allergic disorders by their ability to release a wide variety of pro-inflammatory mediators."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 190,
                    "offsetInEndSection": 329,
                    "text": "A number of studies, however, have demonstrated that mast cells play a beneficial role in innate host defense against bacterial infections."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 512,
                    "text": "Since mast cells clearly play both physiological and pathophysiological functions in the body, it is important to learn about the components of mast cells that drive these responses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 513,
                    "offsetInEndSection": 887,
                    "text": "The functional roles of mast cell in vivo have been principally characterized by comparing the biological responses in mast cell-deficient mice (WBB6F(1)-W/W(v)), their normal wild-type littermates (WBB6F(1)-+/+) and mast cell deficient mice reconstituted locally or systemically with mast cells cultured from the bone marrow cells of WBB6F(1)-+/+ mice (WBB6F(1)-W/W(v)+MC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 888,
                    "offsetInEndSection": 1137,
                    "text": "Recently investigators have demonstrated that mast cell-deficient mice (WBB6F(1)-W/W(v)) can be reconstituted with mast cells derived in vitro from the bone marrow cells of certain gene knock-out mice or genetically-manipulated embryonic stem cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1138,
                    "offsetInEndSection": 1325,
                    "text": "This novel approach of analyzing the biological consequences of gene mutations in mast cells will help us to better understand the role of individual gene products in mast cell responses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1326,
                    "offsetInEndSection": 1425,
                    "text": "In this review, we discuss these new approaches to investigate the functions of mast cells in vivo."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 11,
                    "text": "Mast cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Mast cells are found resident in tissues throughout the body, particularly in association with structures such as blood vessels and nerves, and in proximity to surfaces that interface the external environment."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                "http://www.ncbi.nlm.nih.gov/pubmed/9096671",
                "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                "http://www.ncbi.nlm.nih.gov/pubmed/20519675",
                "http://www.ncbi.nlm.nih.gov/pubmed/21192130",
                "http://www.ncbi.nlm.nih.gov/pubmed/24113466",
                "http://www.ncbi.nlm.nih.gov/pubmed/25041067",
                "http://www.ncbi.nlm.nih.gov/pubmed/11920550"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "Autonomous portable solar ultraviolet spectroradiometer (APSUS) - a new CCD spectrometer system for localized, real-time solar ultraviolet (280-400 nm) radiation measurement."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Terrestrial solar ultraviolet (UV) radiation has significant implications for human health and increasing levels are a key concern regarding the impact of climate change."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 262,
                    "text": "Monitoring solar UV radiation at the earth's surface is therefore of increasing importance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 263,
                    "offsetInEndSection": 431,
                    "text": "A new prototype portable CCD (charge-coupled device) spectrometer-based system has been developed that monitors UV radiation (280-400\u00a0nm) levels at the earth's surface."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 432,
                    "offsetInEndSection": 506,
                    "text": "It has the ability to deliver this information to the public in real time."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 507,
                    "offsetInEndSection": 635,
                    "text": "Since the instrument can operate autonomously, it is called the Autonomous Portable Solar Ultraviolet Spectroradiometer (APSUS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 636,
                    "offsetInEndSection": 759,
                    "text": "This instrument incorporates an Ocean Optics QE65000 spectrometer which is contained within a robust environmental housing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 760,
                    "offsetInEndSection": 911,
                    "text": "The APSUS system can gather reliable solar UV spectral data from approximately April to October inclusive (depending on ambient temperature) in the UK."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 912,
                    "offsetInEndSection": 976,
                    "text": "In this study the new APSUS unit and APSUS system are presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 977,
                    "offsetInEndSection": 1120,
                    "text": "Example solar UV spectra and diurnal UV Index values as measured by the APSUS system in London and Weymouth in the UK in summer 2012 are shown."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                "http://www.ncbi.nlm.nih.gov/pubmed/16793213",
                "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                "http://www.ncbi.nlm.nih.gov/pubmed/12781903",
                "http://www.ncbi.nlm.nih.gov/pubmed/7759722",
                "http://www.ncbi.nlm.nih.gov/pubmed/15851612",
                "http://www.ncbi.nlm.nih.gov/pubmed/9809896",
                "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                "http://www.ncbi.nlm.nih.gov/pubmed/10535368"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "title",
                    "offsetInBeginSection": 74,
                    "offsetInEndSection": 98,
                    "text": "How long is long enough?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Cardioembolism accounts for approximately 20% of ischaemic strokes, and is associated with high mortality and propensity to recurrences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 287,
                    "text": "Approximately, 30% of ischaemic strokes remain cryptogenic despite improved imaging modalities and technological improvements to identify their cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 453,
                    "text": "Of the long list of various cardiac conditions associated with an increased risk of cardioembolic strokes, non-valvular atrial fibrillation is the most common cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 618,
                    "text": "Unsurprisingly, the stroke risk associated with these conditions is highly variable and non-homogenous, with many risk factors additive to the overall risk profile."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 619,
                    "offsetInEndSection": 801,
                    "text": "Treatment with vitamin K-antagonists substantially reduces the long-term complications associated with cardioembolism in some high-risk patients, for example, in atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 802,
                    "offsetInEndSection": 962,
                    "text": "Careful selection of antithrombotic drug regime needs to be carried out in patients individually to minimise the risk of bleeding encountered with such therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1161,
                    "text": "Apart from atrial fibrillation, there is relatively limited evidence for the role of antithrombotic therapy for other cardiac conditions associated with cardioembolism and how long one should treat."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 66,
                    "text": "Increased atrial fibrillation mortality: United States, 1980-1998."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                "http://www.ncbi.nlm.nih.gov/pubmed/8418500",
                "http://www.ncbi.nlm.nih.gov/pubmed/15969767",
                "http://www.ncbi.nlm.nih.gov/pubmed/7651386",
                "http://www.ncbi.nlm.nih.gov/pubmed/20679336",
                "http://www.ncbi.nlm.nih.gov/pubmed/9215863",
                "http://www.ncbi.nlm.nih.gov/pubmed/27334938",
                "http://www.ncbi.nlm.nih.gov/pubmed/25486564",
                "http://www.ncbi.nlm.nih.gov/pubmed/17762884",
                "http://www.ncbi.nlm.nih.gov/pubmed/25755280"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "Regulation of p53 gene expression by a poxviral transcription factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Identification of regulators of p53 expression is a crucial step in understanding the diverse functions of p53 and its role in cellular homeostasis and responsiveness to insult."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 178,
                    "offsetInEndSection": 271,
                    "text": "Several viral proteins inactivate p53 as a modulator of cell cycle progression and apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 272,
                    "offsetInEndSection": 375,
                    "text": "Here, we report that a unique leporipoxviral transcription factor greatly increases levels of p53 mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 376,
                    "offsetInEndSection": 496,
                    "text": "C7, an early transcription factor from malignant rabbit fibroma virus (MV), is an important determinant of MV virulence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 497,
                    "offsetInEndSection": 643,
                    "text": "Its effects on cellular gene expression were studied both during MV infection and in isolation, with C7 DNA cloned into a pKC4 expression plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 644,
                    "offsetInEndSection": 698,
                    "text": "In both settings, C7 caused increased p53 mRNA levels."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 750,
                    "text": "The increased p53 mRNA reflected new transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 900,
                    "text": "C7-induced increased transcription was selective: mRNAs for some cellular genes increased but those for many other genes (e.g., Bc12) were unchanged."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 901,
                    "offsetInEndSection": 1057,
                    "text": "Immunoblot and immunohistochemical analysis of pKC7-transfected and MV-infected cells showed that increased transcription led to an increase in p53 protein."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                "http://www.ncbi.nlm.nih.gov/pubmed/24713815",
                "http://www.ncbi.nlm.nih.gov/pubmed/19444952",
                "http://www.ncbi.nlm.nih.gov/pubmed/26724852",
                "http://www.ncbi.nlm.nih.gov/pubmed/26066476",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151566",
                "http://www.ncbi.nlm.nih.gov/pubmed/24266750",
                "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                "http://www.ncbi.nlm.nih.gov/pubmed/28282874"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "BACKGROUND\nWe evaluated the association between plasma levels of VWF, ADAMTS13 and d-Dimer, which consist on endothelial dysfunction and hypercoagulability biomarkers, and cystatin C with retinopathy in type 1 diabetic patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 326,
                    "text": "METHODS\nPatients were classified according to presence (n=55) or absence (n=70) of retinopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 327,
                    "offsetInEndSection": 450,
                    "text": "Plasma levels of VWF, ADAMTS13, d-Dimer and cystatin C were evaluated by ELISA and ADAMTS13 activity was evaluated by FRET."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 453,
                    "offsetInEndSection": 661,
                    "text": "RESULTS\nPlasma levels of VWF (p=0.033), ADAMTS13 activity (p=0.014), d-Dimer (p=0.002) and cystatin C (p<0.001) were elevated in diabetic patients with retinopathy compared to those without this complication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 662,
                    "offsetInEndSection": 986,
                    "text": "The multivariate logistic regression analysis showed that ADAMTS13 activity (p=0.031) d-Dimer (p=0.015) and cystatin C (p=0.001) remained associated with retinopathy after adjustment for age, diabetes duration, use of statin, use of ACEi or angiotensin antagonist, use of acetylsalicylic acid and glomerular filtration rate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1188,
                    "text": "CONCLUSION\nADAMTS13 activity, d-Dimer and cystatin C are associated with retinopathy in type 1 diabetic patients and are promising biomarkers for the diagnosis and monitoring of diabetic retinopathy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 139,
                    "text": "OBJECTIVE\nThe study aims to determine whether cystatin C is associated with HIV disease and HIV-associated neurocognitive impairment (NCI)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 322,
                    "text": "METHODS\nParticipants included 124 (HIV+ n = 77; HIV- n = 47) older adults (age \u2265 50 years) examined at the University of California, San Diego HIV Neurobehavioral Research Program."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18457726",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                "http://www.ncbi.nlm.nih.gov/pubmed/15797810",
                "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                "http://www.ncbi.nlm.nih.gov/pubmed/6247584",
                "http://www.ncbi.nlm.nih.gov/pubmed/16198385",
                "http://www.ncbi.nlm.nih.gov/pubmed/25823707",
                "http://www.ncbi.nlm.nih.gov/pubmed/25404076",
                "http://www.ncbi.nlm.nih.gov/pubmed/25759741"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 26,
                    "text": "[Cutaneous leishmaniasis]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Leishmaniasis includes a spectrum of different diseases that differ in their clinical appearance and severity and influence the patient's health to varying degrees."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 230,
                    "text": "All the diseases are caused by parasites of the genus Leishmania."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 339,
                    "text": "The simplest and most widely used classifications use the clinical features and the geographic distribution."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 340,
                    "offsetInEndSection": 432,
                    "text": "Cutaneous leishmaniasis can be divided into localized, diffuse, recurrent or post-kala-azar."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 433,
                    "offsetInEndSection": 568,
                    "text": "Using the geographic distribution leishmaniasis of the Old World, is found in Africa, Asia, Middle East, Mediterranean basin and India."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 569,
                    "offsetInEndSection": 625,
                    "text": "Both, cutaneous and visceral leishmaniasis, may develop."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 626,
                    "offsetInEndSection": 783,
                    "text": "In contrast, New World leishmaniasis is caused by leishmania found in Central and South America and cause may cutaneous, mucocutaneous and visceral findings."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15797810",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 74,
                    "text": "Immunopathogenesis of infection with the visceralizing Leishmania species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15797810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Human leishmaniasis is a spectral disease that includes asymptomatic self-resolving infection, localized skin lesions, and progressive visceral leishmaniasis."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                "http://www.ncbi.nlm.nih.gov/pubmed/27306620",
                "http://www.ncbi.nlm.nih.gov/pubmed/23194153",
                "http://www.ncbi.nlm.nih.gov/pubmed/16874847",
                "http://www.ncbi.nlm.nih.gov/pubmed/22717419",
                "http://www.ncbi.nlm.nih.gov/pubmed/22198820"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Interactions of warfarin with other drugs or substances can pose a serious problem."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 84,
                    "offsetInEndSection": 388,
                    "text": "We assessed three drug information compendia-Clinical Pharmacology, ePocrates, and Micromedex-and the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 521,
                    "text": "The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 522,
                    "offsetInEndSection": 610,
                    "text": "Of a total of 648 entries from the four sources, only 50 were common to all the sources."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 611,
                    "offsetInEndSection": 797,
                    "text": "The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 798,
                    "offsetInEndSection": 910,
                    "text": "These sources were then examined for classification by severity of interaction and the underlying evidence base."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 911,
                    "offsetInEndSection": 1075,
                    "text": "This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 204,
                    "text": "BACKGROUND\nBecause interactions with warfarin represent a serious risk to patients, drug information sources used by clinicians should contain accurate, timely, and practical drug interaction information."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                "http://www.ncbi.nlm.nih.gov/pubmed/26834368",
                "http://www.ncbi.nlm.nih.gov/pubmed/17509761",
                "http://www.ncbi.nlm.nih.gov/pubmed/16051171",
                "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                "http://www.ncbi.nlm.nih.gov/pubmed/25274322",
                "http://www.ncbi.nlm.nih.gov/pubmed/16163658",
                "http://www.ncbi.nlm.nih.gov/pubmed/9973880",
                "http://www.ncbi.nlm.nih.gov/pubmed/24928524",
                "http://www.ncbi.nlm.nih.gov/pubmed/24520350"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "Work-related musculoskeletal disorders among physical therapists: an online survey."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "PURPOSE\nTo evaluate the rates and characteristics of musculoskeletal disorders (MSDs) in physical therapists (PTs) according to their specialty and setting."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 322,
                    "text": "METHOD\nParticipants completed an online questionnaire including 15 demographic questions, 7 work-related and 8 injury-related questions for 9 different body parts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 473,
                    "text": "RESULTS\nComplete responses were obtained from 121 PTs; 96% reported MSD symptoms during the previous 12 months, 64% affecting at least 3 body parts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 572,
                    "text": "The body parts with the highest prevalence of symptoms were the low back (66%) and the neck (61%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 573,
                    "offsetInEndSection": 796,
                    "text": "For PTs specialized in acute care, geriatrics and pediatrics, the body part most commonly affected was the low back, while for PTs specialized in orthopedics and neurology, the body part most commonly affected was the neck."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 797,
                    "offsetInEndSection": 1012,
                    "text": "Regarding work settings, the low back was the most commonly affected for PTs working in skilled nursing facilities, outpatient clinics and hospitals, and the neck in PTs working in academic and home health settings."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1015,
                    "offsetInEndSection": 1116,
                    "text": "CONCLUSIONS\nMSDs are common among PTs; the body parts most often affected were the low back and neck."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1117,
                    "offsetInEndSection": 1202,
                    "text": "The prevalence and body parts affected varied by practice setting and specialty area."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1203,
                    "offsetInEndSection": 1326,
                    "text": "The findings can help informing the design of evidence-based rehabilitation, prevention, training and educational programs."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                "http://www.ncbi.nlm.nih.gov/pubmed/10834971",
                "http://www.ncbi.nlm.nih.gov/pubmed/19116360",
                "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                "http://www.ncbi.nlm.nih.gov/pubmed/2069374",
                "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                "http://www.ncbi.nlm.nih.gov/pubmed/25352679"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "From February through July, 2000, there was an accumulation of mecA-negative borderline resistant Staphylococcus aureus (BORSA) in the Department of Dermatology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 212,
                    "text": "BORSA was isolated in 37 samples from 11 patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 213,
                    "offsetInEndSection": 390,
                    "text": "The isolates were typed by antibiogram, phage type, pulsed-field gel electrophoresis (PFGE), and spa genotyping that confirmed that they were indistinguishable from one another."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 391,
                    "offsetInEndSection": 465,
                    "text": "In May, 2000, an intervention was initiated focusing on infection control."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 466,
                    "offsetInEndSection": 555,
                    "text": "In-patients with BORSA were discharged and antibiotic treatment was stopped, if possible."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 670,
                    "text": "Emphasis was put on disinfection of shared utensils and individualization of previously shared creams and lotions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 671,
                    "offsetInEndSection": 773,
                    "text": "After the intervention, BORSA was isolated from another 3 patients before the outbreak was terminated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 870,
                    "text": "A case-control study was undertaken to identify possible risk factors for being a BORSA patient."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 871,
                    "offsetInEndSection": 1003,
                    "text": "Compared to the controls, the patients with BORSA had more severe skin disease, were more often hospitalized, and had more bed days."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                "http://www.ncbi.nlm.nih.gov/pubmed/17565757",
                "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                "http://www.ncbi.nlm.nih.gov/pubmed/21108403",
                "http://www.ncbi.nlm.nih.gov/pubmed/17574010",
                "http://www.ncbi.nlm.nih.gov/pubmed/15884233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27075776",
                "http://www.ncbi.nlm.nih.gov/pubmed/23099646"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Possible mechanisms and gene involvement in speech problems in the 22q11.2 deletion syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "The 22q11.2 deletion syndrome represents a contiguous gene syndrome with a highly variable phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 102,
                    "offsetInEndSection": 158,
                    "text": "To date, over 180 clinical features have been described."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 225,
                    "text": "Studies have been done in order to identify the responsible genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 226,
                    "offsetInEndSection": 329,
                    "text": "Several candidate genes such as TBX1 and COMT seem to be important in the development of the phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 448,
                    "text": "One of the prevalent and serious problems encountered by patients with the 22q11.2 deletion is difficulty with speech."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 449,
                    "offsetInEndSection": 604,
                    "text": "This may be due to a number of factors such as adenoid hypoplasia, muscle hypotonia, platybasia, upper airway asymmetry, and neuroanatomical abnormalities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 733,
                    "text": "The complex interaction of these factors leads to less favourable results after surgery to correct velopharyngeal insufficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "abstract",
                    "offsetInBeginSection": 734,
                    "offsetInEndSection": 963,
                    "text": "This article offers a theoretical overview and proposes future research to investigate which factors are indeed responsible for the speech problems encountered by patients with the 22q11.2 deletion and identify responsible genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "[Influence of selected family environment factors on the child's speech development]."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "OBJECTIVE\nTo study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 199,
                    "offsetInEndSection": 343,
                    "text": "MATERIALS AND METHODS\nProximity extension assays were used to measure 145 proteins in 632 controls and 344 cases with non-communicable diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 438,
                    "text": "RESULTS\nGenetic and lifestyle factors explained 20-88% of the variation in healthy controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 439,
                    "offsetInEndSection": 517,
                    "text": "Adjusting for these factors reduced the number of candidate biomarkers by 63%."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Phosphodiesterase activities in transgenic tobacco plants associated with the movement protein of tobacco mosaic virus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Hydrolytic activities of leaf extracts from normal and transgenic plants, with (+ MP) and without (-MP) the movement protein of tobacco mosaic virus, were examined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 531,
                    "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 532,
                    "offsetInEndSection": 702,
                    "text": "The + MP plant lines, as compared with other transgenic plants, exhibited higher nucleotide-phosphodiesterase activity in the soluble as well as in the membrane fraction."
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                "http://www.ncbi.nlm.nih.gov/pubmed/23199790",
                "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                "http://www.ncbi.nlm.nih.gov/pubmed/24681576",
                "http://www.ncbi.nlm.nih.gov/pubmed/28055004",
                "http://www.ncbi.nlm.nih.gov/pubmed/20978399",
                "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                "http://www.ncbi.nlm.nih.gov/pubmed/19674341"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Mendelian Randomization versus Path Models: Making Causal Inferences in Genetic Epidemiology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 80,
                    "text": "OBJECTIVE\nThe term Mendelian randomization is popular in the current literature."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 81,
                    "offsetInEndSection": 226,
                    "text": "The first aim of this work is to describe the idea of Mendelian randomization studies and the assumptions required for drawing valid conclusions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 227,
                    "offsetInEndSection": 352,
                    "text": "The second aim is to contrast Mendelian randomization and path modeling when different 'omics' levels are considered jointly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 355,
                    "offsetInEndSection": 464,
                    "text": "METHODS\nWe define Mendelian randomization as introduced by Katan in 1986, and review its crucial assumptions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 465,
                    "offsetInEndSection": 592,
                    "text": "We introduce path models as the relevant additional component to the current use of Mendelian randomization studies in 'omics'."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 593,
                    "offsetInEndSection": 715,
                    "text": "Real data examples for the association between lipid levels and coronary artery disease illustrate the use of path models."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 718,
                    "offsetInEndSection": 836,
                    "text": "RESULTS\nNumerous assumptions underlie Mendelian randomization, and they are difficult to be fulfilled in applications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 837,
                    "offsetInEndSection": 961,
                    "text": "Path models are suitable for investigating causality, and they should not be mixed up with the term Mendelian randomization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 962,
                    "offsetInEndSection": 1089,
                    "text": "In many applications, path modeling would be the appropriate analysis in addition to a simple Mendelian randomization analysis."
                }
            ]
        }
    ]
}